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Summary 
Millions of pigs are produced in Denmark each year, making it one of the largest pig producing 
countries in the world. Production of pigs can be associated with various challenges such as 
environmental and management issues and with the presence of pathogens. Respiratory and 
intestinal diseases caused by pathogens are of major importance to the pig production as it can 
result in reduced productivity, impaired animal welfare, increased mortality or morbidity. 
Vaccination and medical treatment are often initiated based on clinical observations and lacks 
support from laboratory investigations. This can lead to an overuse of medication and suboptimal 
vaccination programs. A reason why laboratory diagnostic analyses are often neglected is related to 
the high costs associated with the diagnostics and difficulties in interpretation of the results of 
random cross-sectional samples.  
This PhD thesis consists of an introduction in which the project and relevant background is 
introduced. Here, the focus is on influenza A virus (IAV), especially in pigs, and on respiratory and 
enteric viral and bacterial pathogens, which all have an impact on the Danish pig production. 
Furthermore, the background contains a section describing the history of methodology used for 
diagnostic analyses with the greatest focus put on polymerase chain reaction (PCR). The results of 
the work performed during the PhD are presented in the form of three manuscripts. Finally, the 
three manuscripts and suggestions to further work are discussed in a broader context.  
     Manuscript I focus on the design and development of a high-throughput system to improve 
surveillance of swine influenza A virus (swIAV) and lower the costs of virus subtyping. For this, 
the high-throughput real-time PCR (qPCR) BioMark platform (Fluidigm) was used and optimized. 
To validate the platform, 12 different qPCR assays specific for various hemagglutinin and 
neuraminidase gene lineages relevant for swIAV and six different assays specific for the internal 
genes of the 2009 human pandemic strain (A(H1N1)pdm09) were tested. To test the sensitivity and 
specificity of the established high-throughput system, virus isolates and field samples, which had 
earlier been subtyped by full genome sequencing or multiplex reverse transcription qPCR (RT-
qPCR), respectively, were used. Based on our findings, it was concluded that the high-throughput 
system is sensitive and specific and, thereby, the system provides a cost-effective alternative for 
subtyping of swIAVs.    
     In manuscript II, a high-throughput diagnostic system specific for 17 respiratory and enteric viral 
and bacterial pathogens was designed and established again using the high-throughput qPCR 
BioMark platform (Fluidigm). A total of 21 qPCR assays were validated and optimized to run under 
Summary 
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the same reaction conditions. Furthermore, the sensitivity and specificity were assessed based on 
testing of known positive samples. The results revealed a performance of the diagnostic system 
similar to that of the qPCR analyses on the current qPCR platform. In addition, by using the high-
throughput diagnostic system it is possible to offer diagnostic services with reduced costs and 
turnover time. 
     Manuscript III describes three monthly sampling of oral fluid and faecal sock samples together 
with observations of clinical signs in six nursery and four finisher herds in Denmark. The collected 
samples were analysed with the high-throughput diagnostic system described in manuscript II and 
the occurrence of significant correlation between presence of pathogen and clinical signs, such as 
coughing and diarrhoea, was investigated. The study revealed that swIAV, porcine circovirus type 2 
(PCV2), porcine cytomegalovirus (PCMV), Brachyspira pilosicoli, Lawsonia intracellularis, 
Escherichia coli fimbria type F4 and F18 were prevalent in several of the herds. Furthermore, for 
some of the pathogens a significant correlation was observed between their detection and the 
presence of coughing and/or diarrhoeic events. The study further showed that the use of the high-
throughput diagnostic system for continuous monitoring of pathogens provides a broader 
knowledge on the distribution of pathogens in a given herd. This information can be useful for 
veterinary consultancy as it creates a more objective basis for intervention, including treatment 
regimens and vaccination strategies. 
Based on the studies described in manuscripts I, II and III, it was concluded that the use of the high-
throughput qPCR BioMark platform provides a new and innovative way of carrying out diagnostic 
analyses. Changing to this cheaper platform will favour the use of laboratory analyses in the pig 
industry and provide a more objective basis for the selection of preventive measures to the benefit 
of animal health, animal welfare, production economics and food safety. The high-throughput 
system is presently under establishment in the Diagnostic Centre at the National Veterinary 
Institute, Technical University of Denmark and it will soon be offered to costumers as a diagnostic 
service. 
Resumé 
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Resumé (summary in Danish) 
I Danmark produceres årligt millioner af grise, hvilket gør det til et af verdens største 
svineproduktionslande. Produktion af grise kan være forbundet med forskellige udfordringer såsom 
miljø- og håndteringsproblemer og tilstedeværelsen af patogener. Respiratoriske- og 
tarmsygdomme forårsaget af patogener har stor betydning for svineproduktionen idet de kan 
medføre nedsat produktivitet, forringet dyrevelfærd, øget dødelighed og sygelighed. Vaccination og 
medicinsk behandling påbegyndes ofte baseret på kliniske observationer og uden støtte fra 
laboratorieundersøgelser. Dette kan føre til overforbrug af medicin og suboptimale 
vaccinationsprogrammer. En af årsagerne til at laboratoriediagnostiske analyser ofte forsømmes, er 
relateret til de høje omkostninger forbundet med diagnostik og vanskeligheder forbundet med 
fortolkning af resultater fra tilfældige tværsnitsprøver. 
  
Denne PhD afhandling består af en introduktion, hvor projektet og den relevante baggrund 
introduceres. Her er det primære fokus lagt på influenza A virus (IAV), især hos svin, og på 
respiratoriske og enteriske virale og bakterielle patogener, som alle har indflydelse på den danske 
svineproduktion. Desuden indeholder baggrunden et afsnit omhandlende de typiske metoder 
anvendt til diagnostiske analyser med et særligt fokus på polymerasekædereaktion (PCR). 
Resultaterne af det arbejde, der er udført under PhD-studiet, præsenteres i form af tre manuskripter. 
Endelig diskuteres resultaterne af de tre manuskripter og forslag til videre arbejde i en bredere 
sammenhæng. 
     Manuskript I fokuserer på design og udvikling af et high-throughput system til forbedret 
overvågning af svine influenza A virus (swIAV) og reducering af omkostningerne ved virus 
subtyping. Til dette blev high-throughput real-time PCR (qPCR) BioMark platformen (Fluidigm) 
brugt og optimeret. Til validering af platformen blev 12 forskellige qPCR assays med specificitet 
for forskellige hemagglutinin- og neuraminidase gener, der er relevante for swIAV, og seks 
forskellige assays, der var specifikke for de interne gener af den 2009 humane pandemisk stamme 
(A(H1N1) pdm09), testet. For at teste følsomheden og specificiteten af det etablerede high-
throughput system anvendtes virusisolater og feltprøver som tidligere var subtypet med henholdsvis 
fuld genom-sekventering eller multiplex revers transkription qPCR (RT-qPCR). Baseret på vores 
resultater kunne det konkluderes, at high-throughput systemet er følsomt og specifikt, hvilket gør 
dette system til et omkostningseffektivt alternativ til subtyping af swIAV. 
Resumé 
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     I manuskript II beskrives etableringen af et high-throughput diagnostisk system specifikt for 17 
respiratoriske og enteriske virale og bakterielle patogener igen ved anvendelse af high-throughput 
qPCR BioMark platformen (Fluidigm). I dette system blev i alt 21 qPCR assays valideret og 
optimeret til at køre under de samme reaktionsbetingelser. Endvidere blev følsomheden og 
specificiteten vurderet baseret på testning af kendte positive prøver. Resultaterne afslørede at 
præstationen af det diagnostiske system svarer til den nuværende qPCR platform. Dermed er det 
muligt at tilbyde diagnostiske tjenester med reducerede omkostninger og svartid ved at anvende det 
nyudviklede high-throughput diagnostiske system. 
     Manuskript III beskriver tre månedlige prøveudtagninger af spyt og fækale sokkeprøver sammen 
med observationer af kliniske tegn i seks fravænnings- og fire slagtesvinsbesætninger i Danmark. 
De indsamlede prøver blev analyseret med systemet beskrevet i manuskript II og forekomsten af 
patogener og korrelation mellem tilstedeværelse af patogener og kliniske tegn, såsom hoste og 
diarré, blev undersøgt. Undersøgelsen viste, at swIAV, porcine circovirus type 2 (PCV2), porcin 
cytomegalovirus (PCMV), Brachyspira pilosicoli, Lawsonia intracellularis, Escherichia coli 
fimbrie type F4 og F18 var fremherskende i flere af besætningerne. Endvidere blev der for nogle af 
patogenerne observeret en signifikant korrelation mellem deres påvisning og tilstedeværelsen af 
hoste- og/eller diarré. Undersøgelsen viste endvidere at brugen af et high-throughput diagnostisk 
system til vedvarende overvågning af patogener giver en bredere viden om fordelingen af patogener 
i en given besætning. Disse oplysninger kan være nyttige i veterinærrådgivning da det skaber et 
mere objektivt grundlag for intervention, herunder behandlingsregimer og vaccinationsstrategier. 
 
Baseret på de undersøgelser, der er beskrevet i manuskripterne I, II og III, blev det konkluderet, at 
brugen af  high-throughput qPCR BioMark platformen giver en ny og innovativ måde at udføre 
diagnostiske analyser på. Ved at skifte til denne platform er det muligt for brugerne at reducere 
omkostninger og tid brugt på analyse. Dette vil favorisere brugen af laboratorieanalyser i 
svineindustrien og give et mere objektivt grundlag for udvælgelse af forebyggende foranstaltninger 
til gavn for dyresundhed, dyrevelfærd, produktionsøkonomi og fødevaresikkerhed. High-throughput 
systemet er i øjeblikket under etablering i det Diagnostiske Center hos Veterinærinstituttet, 
Danmarks Tekniske Universitet, og det vil snart blive tilbudt til forbrugerne som en diagnostisk 
service. 
Introduction and aims 
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1 Introduction and aims 
In 2015, the National Veterinary Institute, Technical University of Denmark, started a project in 
collaboration with SEGES and University of Copenhagen with the title “Improved surveillance of 
health and production in pigs”. The cooperation aimed to improve the health monitoring programs 
in pig herds to ensure more efficient and rapid detection of infectious diseases in the early stage of 
disease. In addition, it should improve identification of the infections playing the most significant 
role in the herds. A part of the project was to develop a diagnostic system suitable for analysis of a 
high number of samples and for screening for several different pathogens simultaneously. As a part 
of this project, the Danish Swine Leary Foundation supported a PhD project at the National 
Veterinary Institute, Technical University of Denmark to establish a laboratory diagnostic system 
that could fulfil these criteria. 
     Thus, the main aim of this PhD project was the development of high-throughput diagnostic 
systems for detection and typing of veterinary pathogens (viruses and bacteria) with major 
importance to the health and welfare of Danish swine. 
      
The main activities of the PhD comprise three projects with the following focuses: 
1. Establishment, optimization and validation of a high-throughput system for rapid and 
specific subtyping of swine influenza A viruses (swIAVs) (manuscript I) 
2. Establishment, optimization and validation of a high-throughput diagnostic system specific 
for the most relevant Danish porcine viral and bacterial pathogens (manuscript II) 
3. Validation of the high-throughput diagnostic system (manuscript II) on field samples from 
nursery and finisher pigs collected as a part of a prospective study in ten Danish pig herds. 
Here, the high-throughput diagnostic system was used to analyse the connection between 
detection of pathogen(s) and the observed clinical signs of diseases (manuscript III) 
 
1.1 Outline of the PhD thesis 
The background section contains an overall introduction to influenza A virus (IAV) in pigs, and to 
respiratory and enteric viral and bacterial pathogens with impact on the Danish pig production. 
Furthermore, the methodology used for the diagnostic analyses with the greatest focus put on 
polymerase chain reaction (PCR) is described. The own studies section contains the three 
manuscripts of the PhD project. The discussion and perspectives section contains a general 
Introduction and aims 
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discussion of the PhD project and suggestions to further work. Lastly, the PhD thesis is completed 
with a conclusion section in which the main findings are highlighted.   
Background  
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2 Background 
2.1 Influenza A virus 
2.1.1 Taxonomy and structure 
The genus Influenza virus A belongs to the family Orthomyxoviridae, which also comprises the 
genera Influenza virus B, Influenza virus C, Thogotovirus, Isavirus and the newly described 
Influenza virus D (Hause et al., 2014; Webster et al., 1992). The natural reservoir of influenza A 
viruses (IAVs) are aquatic birds, however, the virus has been isolated from a wide range of species 
including pigs, seals, humans, cats, dogs and horses (Webster et al., 1992). The clinical signs of 
IAV include acute onset of disease, fever, anorexia, coughing, nasal discharge, sneezing, exhaustion 
and apathy (Zell et al., 2013). Influenza B viruses have been isolated from humans and seals and the 
clinical symptoms caused by these are similar to those of IAV, but in a milder form. Influenza C 
viruses have been isolated from humans and swine and generally cause only mild disease in the 
upper respiratory tract (Baigent and McCauley, 2003; Osterhaus et al., 2000). The newly discovered 
influenza D viruses have so far been isolated from pigs and cattle affected by respiratory disease 
(Chiapponi et al., 2016; Ducatez et al., 2015; Hause et al., 2014).  
     IAV is an enveloped single-stranded, negative sense RNA virus with a segmented genome of 
approximately 13.6 kb. In general, the IAV particles are pleomorphic and roughly spherical with a 
size of 80-120 nm in diameter, however, some are filamentous with a size of 1 µm or longer 
(Fujiyoshi et al., 1994; Webster et al., 1992). The genome of IAV consists of eight gene segments 
(Figure 1), which are coding for the surface glycoproteins hemagglutinin (HA) and neuraminidase 
(NA), basic polymerase 1 protein (PB1), basic polymerase 2 protein (PB2), acidic polymerase 
protein (PA), nucleoprotein (NP), matrix proteins (M1 and M2) and the non-structural proteins 
(NS1 and NS2, also called nuclear export protein (NEP)). The size of the gene segments range 
between 890-2341 nucleotides (230-759 amino acids). Some of the segments encode a single 
protein, whereas other segments encode for several different proteins, where the function for some 
of the detected proteins have not been fully elucidated yet (Bouvier and Palese, 2008; te Velthuis 
and Fodor, 2016). The viral envelope consists of a host-derived lipid bilayer in which the 
transmembrane proteins HA, NA and M2 are embedded. While HA and NA are anchored in the 
lipid bilayer, the cholesterol-binding protein M2 is not tightly associated with the lipid bilayer. 
Background  
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Figure 1 Schematic representation of Influenza A virus. The surface glycoproteins hemagglutinin (HA) and neuraminidase (NA) and 
the matrix 2 (M2) protein are located in the viral envelope. The matrix 1 (M1) protein is anchored inside the viral envelope 
underneath the lipid membrane. In the virion core, each RNA segments are complexed with the polymerase complex (PA, PB1 and 
PB2) and the nucleoprotein (NP) to form viral ribonucleoproteins (vRNPs) (Scolari et al., 2009).      
     The major envelope protein HA is a homotrimer responsible for receptor binding and membrane 
fusion and consists of individual monomers composed of the two polypeptide chains HA1 and 
HA2. The second most abundant envelope protein NA is a homotetramer, which function is to 
cleave receptor binding (sialic acid linkages) and release the viral progeny. M2, the least abundant 
envelope protein, is a homotetramer functioning as a ion channel (Nayak et al., 2009; Schroeder et 
al., 2005; Webster et al., 1992). The M1 protein is anchored inside the viral envelope underneath 
the lipid membrane where it forms a shell surrounding the virion core. Inside the virion core, each 
viral RNA (vRNA) segment is folded into a rod-shaped double-helix viral ribonucleoprotein 
complex (vRNP), where the vRNA segments are bound to the NP protein and to the heterotrimeric 
viral polymerase complex consisting of PB1, PB2 and PA. The vRNPs play an important role in the 
virus infection cycle (Cheung and Poon, 2007; Webster et al., 1992; Zheng and Tao, 2013).  
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2.1.2 The replication cycle of influenza A virus 
The first stage in viral infection caused by IAVs is the recognition and binding of HA to α2.3- or 
α2.6-linked sialic acid containing receptors on the host cell surface. IAVs from different host 
species show different receptor binding preferences; in general, human and swine IAVs favour 
binding to α2.6-linked sialic acid, whereas avian IAVs shows preference for the α2.3-linked sialic 
acid. The sialic acid binding specificity of HA is one of the major determinants for controlling viral 
tropism and host specificity (Imai and Kawaoka, 2012; Shinya et al., 2006; Trebbien et al., 2011). 
Upon cell attachment, IAV enters the cell via receptor-mediated endocytosis (Figure 2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 Schematic representation of the influenza A virus replication cycle. Influenza A virus binds to sialic acid 
containing receptors on the host cell surface and the virus enters the cell by receptor-mediated endocytosis. The acidic 
environment in the endosome facilitates the release of the vRNPs into the host cell cytoplasm. The vRNPs is then 
transported into the nucleus where transcription and replication takes place. Polyadenylated and capped viral mRNA are 
exported to the cytoplasm for translation into viral proteins by the host translational machinery. Some of the newly 
synthesized viral proteins enter the nucleus to be included in new vRNPs. The newly formed vRNPs are exported from the 
nucleus and transported to the site of assembly at the host cell membrane, where new virions are packaged and released (te 
Velthuis et al. 2016).  
Background  
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The low pH of the endosome triggers a conformational change of the HA monomers (HA0), which 
is cleaved into HA1 and HA2 by trypsin-like enzymes (Lazarowitz et al., 1973). The cleavage of 
HA results in generation of the fusion peptide at the N-terminus of HA2, which mediates the fusion 
of the viral membrane with the endosomal membrane and ultimately the release of the vRNPs into 
the host cell cytoplasm. The vRNPs are then transported into the host cell nucleus through nuclear 
pores by means of virus proteins’ nuclear localization signals for transcription and replication of 
vRNA (Martin and Helenius, 1992). Inside the nucleus, the viral RNA-dependent RNA polymerase 
(RdRp – comprised of PB1, PB2, PA) uses the negative-sense vRNA as a template for synthesis of 
messenger RNA (mRNA), which then acts as template for viral protein synthesis, and for synthesis 
of the positive-sense complementary RNA (cRNA) intermediate, which serves as a template for 
production of new negative-sense genomic vRNA (Bouvier and Palese, 2008). Transcription is 
activated in the nucleus and is initiated by an event named “cap-snatching”, in which the PB2 
subunit binds to the 5’ cap end of the host pre-mRNA, which are then cleaved after 10–15 
nucleotides by the endonucleolytic activity of the PA subunit. The short capped leader sequence is 
subsequently used as a viral primer for extension, which is carried out by the PB1 subunit, using 
vRNA as a template, generating capped viral mRNAs (Dias et al., 2009; Plotch et al., 1981; York 
and Fodor, 2013). The presence of a short sequence of five to seven uracil (U) residues in the 
vRNA results in the transcription of viral mRNA with a string of adenosine residues that form a 
poly(A) tail. Polyadenylated and capped viral mRNA are then exported to the cytoplasm for 
translation into viral proteins by the host translational machinery. Furthermore, vRNA is also used 
as template for synthesis of positive-sense cRNAs, which are replication intermediates responsible 
for directing the synthesis of new negative-sense vRNAs. Newly translated NP, PB1, PB2 and PA 
are imported back to the nucleus, where newly synthesised vRNAs are encapsidated by free NP 
leading to the formation of new vRNPs, which are then exported from the nucleus and transported 
across the cytoplasm to the cell membrane where virus assembly takes place. Nuclear export of 
nascent mRNAs and vRNPs into the cytoplasm is facilitated by M1 and NEP (Cros and Palese, 
2003; Zheng and Tao, 2013). Besides permitting nucleus export, M1 is also involved in 
transcriptional downregulation (Perez and Donis, 1998). The newly translated envelope proteins 
HA, NA and M2 are transported to the cell membrane after passing through the host cell secretory 
pathway for post-translational modification. At the host cell membrane, these proteins are 
incorporated into the lipid bilayer and together with an accumulation of the M1 protein at the 
cytoplasmic site of the cell membrane initiates the budding process. In the budding virus particle, 
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vRNPs are packed together with the mentioned proteins. The newly formed virion remains bound to 
the host cell membrane until the sialic acid containing receptor is cleaved by the enzymatic activity 
of NA, which entails release from the host cell. For the new IAV to be infectious, successful 
assembling and packing of virion are required (Bouvier and Palese, 2008; Kuiken et al., 2006).  
 
2.1.3 Evolution of influenza A virus 
The genetic diversity of IAVs is enormous and the antigenic evolution of viruses is mainly 
mediated through mutation of the virus itself, called antigenic drift, and through exchange of gene 
segments, referred to as antigenic shift or reassortment. The antigenic drift is the gradual evolution 
of IAVs caused by frequent mutations, which occur due to lack of proofreading capacity of the viral 
RNA-polymerase (viral quasispecies). Selection pressure on the virus ensures that a small subset of 
the new virus variants contains some advantage over the parent and, hence, only the positive 
selected variants will survive. Mutations that cause changes in the antibody binding site will inhibit 
the efficiency of the host antibodies with specificity towards previously circulating strains and this 
will allow the virus to spread more rapidly among the population (Carrat and Flahault, 2007; 
Zambon, 1999).  
     Antigenic shift or reassortment occurs when a host cell is simultaneously infected by more than 
one IAV strain (Figure 3). In such a case, the gene segments from the different IAVs can be 
interchanged during the virion packaging and a new IAV variant is produced. The new reassorted 
strain can end up containing a genetic composition, which is entirely unknown for the population, 
which in the worst case can cause a new IAV pandemic (Zambon, 1999).       
     
 
Figure 3 Schematic drawing illustrating antigenic shift/reassortment. Two influenza A viruses with different gene 
segments (blue and orange) are infecting the same cell. The gene segments are interchanged during the virion 
packaging and a new influenza A virus variant is produced. The drawing is made by Ramona Trebbien. 
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2.1.4 Classification of influenza A virus 
Classification of IAVs into subtypes are based on the surface glycoproteins HA and NA. Currently, 
16 different HA (H1-H16) and nine different NA (N1-N9) subtypes have been described and 
isolated from aquatic birds. Recently, the subtypes H17N10 and H18N11 have been discovered, but 
they have so far only been isolated from bats (Fouchier et al., 2005; Wu et al., 2014). 
 
2.1.5 Influenza A virus in European pigs  
Influenza A virus in swine (swIAV) was first observed in 1918, which coincided with the human 
influenza pandemic “the Spanish flu” which resulted in the death of millions of people worldwide. 
It was not before 1930 that the virus was isolated and identified (Shope, 1931). Later, the virus was 
classified as an H1N1 subtype and named the “classical swine influenza”, which is used today for 
H1N1 subtypes with similarity to the original strain (Brown, 2000; Reid et al., 1999). After the 
discovery of the classical swine H1N1 virus, the virus continued to circulate in the United States, 
but disappeared from Europe until 1976 when the virus reappeared in Italy and spread to other 
European countries (Brown, 2000; Nardelli et al., 1978). Today, the dominant H1N1 subtype in 
European pigs is of avian origin, referred to as avian-like H1N1, which was introduced from 
waterfowls to pigs around 1979 (Pensaert et al., 1981). The avian-like H1N1 is genetically and 
antigenically distinct from the classical swine H1N1. The classical swine H1N1 has been replaced 
by the avian-like H1N1 in Europe, where it is now one of the most predominant subtype (Brown, 
2013; Simon et al., 2014).   
     Following the 1968 human pandemic, referred to as the “Hong Kong flu”, an H3N2 virus of 
human origin was identified in pigs. In the 1970s, the virus was transmitted to and got established in 
pigs, however, without causing any clinical signs of disease (Miwa et al., 1987; Ottis et al., 1982). 
Around 1984, a reassorted H3N2, which induce typical swine influenza symptoms, was discovered. 
This virus was a result of a reassortment event between the human-like H3N2 and the avian-like 
H1N1, in which the HA and NA genes were of human origin and the six other gene segments of 
avian descent (Castrucci et al., 1993). This porcine-like H3N2 lineage is now the dominant 
genotype of the H3N2 subtype in European pigs (Simon et al., 2014).   
     In the late 1980s, an H1N2 virus with HA origins from the classical swine H1N1 and NA from 
the porcine-like H3N2 was isolated from pigs in France (Gourreau et al., 1994). However, although 
the H1N2 virus was associated with clinical disease it did not appear to spread widely in Europe. In 
1994, another H1N2 reassortant was isolated for the first time in Great Britain. In this case, the HA 
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gene was derived from a human seasonal H1N1 virus, which was circulating in humans in the 
1980s, while the NA gene originated from the porcine-like H3N2 and the internal genes from the 
avian-like H1N1 (Brown et al., 1995, 1998). This human-like reassortaed swine H1N2 is the 
predominant virus within this subtype in Europe, but it has never been detected in Denmark. 
Furthermore, in 2003 a new reassortant H1N2, containing the HA gene from the avian-like H1N1 
and the NA gene from the porcine-like H3N2, was found in Denmark (Trebbien et al., 2013). This 
avian-like H1N2 virus became established in several European countries including Denmark, where 
it is now one of the most prevalent subtypes (Simon et al., 2014).     
     Following the human pandemic in 2009, caused by a novel H1N1 virus, a fourth IAV lineage 
entered the global pig population. The human pandemic H1N1 strain (A(H1N1)pdm09) is now 
enzootic in pigs globally and this virus contains a unique gene constellation not previously 
described or reported. Six of the gene segments (PB2, PB1, PA, HA, NP, NS) show close homology 
to the North American triple-reassortant swIAV, whereas the last two segments (NA, M) show 
closest homology to the Eurasian avian-like H1N1 linage (Garten et al., 2009; Smith et al., 2009). 
The A(H1N1)pdm09 virus has been established in several European countries including Denmark, 
where it is one of the most prevalent subtypes (Simon et al., 2014). Furthermore, reassortants 
between the predominant enzootic swIAVs and the A(H1N1)pdm09 have been observed (Starick et 
al., 2011; Watson et al., 2015) and together with spillover of seasonal human H3 and human N2 
segments, which have been observed in Danish pigs (Breum et al., 2013; Krog et al., 2017), these 
reassortants can carry zoonotic and even pandemic potential. 
 
2.2 Respiratory pig pathogens  
Respiratory diseases are one of the major diseases in pigs worldwide and are of great economic 
importance due to clinical and subclinical diseases, which can influence productivity, reduce animal 
welfare and can have high treatment cost (Hansen et al., 2010). Respiratory diseases can be caused 
by a wide range of pathogens, and in most cases is the result of a multifactorial problem including 
several pathogens (Palzer et al., 2008). Often a primary infection can pave the way for a secondary 
infection, which can complicate the course of disease and thereby delay the recovery and in the 
worst case lead to death. Pathogens causing respiratory diseases vary significantly between 
countries, regions, production sites and herds (Opriessnig et al., 2011). Selected respiratory disease-
causing pathogens with high impact in the Danish pig production will be described in the following 
sections with focus on pathogenesis and clinical signs. 
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2.2.1 Pathogenesis and clinical signs of virus infections  
2.2.1.1 Porcine cytomegalovirus  
Porcine cytomegalovirus (PCMV) is an enveloped virus with a double stranded linear DNA genome 
and belongs to the family Herpesviridae, the subfamily Betaherpesvirinae and the genus 
Cytomegalovirus (Roizmann et al., 1992). PCMV is enzootic in pig populations throughout the 
world and infection can occur in all age groups. The virus can persist latently within cells and can 
be activated during stress or immunosuppression (Mueller and Fishman, 2004). The major sites of 
infection are the nasal turbinates and the upper respiratory tract. Infection with PCMV can lead to 
foetal and piglet death, inclusion body rhinitis, pneumonia, dysplasia and poor weight gain in 
susceptible herds, while in herds where management conditions tend to be good the virus may be 
endemic without causing any clinical disease (Hamel et al., 1999; Liu et al., 2013). 
 
2.2.1.2 Porcine circovirus type 2 and porcine circovirus type 3 
Porcine circovirus type 2 (PCV2) is a small, non-enveloped, circular single-stranded DNA virus, 
belonging to the family Cirocoviridae and the genus Circovirus (Meehan et al., 1998). PCV2 is 
widespread in pig herds throughout the world and four genotypes termed a, b, c and d have been 
described for PCV2 (Dupont et al., 2008; Segalés et al., 2008; Xiao et al., 2015). PCV2 is 
associated with a number of disease syndromes, such as post-weaning multisystemic wasting 
syndrome (PMWS), in which PCV2 is considered to be the causative agent. PMWS affects pigs 
predominantly between five and 15 weeks of age and the syndrome is characterized by wasting, 
dyspnoea, paleness of the skin, lesions in lymphoid tissues, enlarged lymph nodes, diarrhoea and 
increased mortality (Allan and Ellis, 2000; Baekbo et al., 2012; Segalés and Domingo, 2002). Not 
all pigs infected by PCV2 will develop PMWS, since it is a multifactorial disease in which other 
factors in addition to PCV2 are needed to trigger clinical disease (Segalés et al., 2005). Besides 
PMWS, PCV2 has also been linked to enteritis, pneumonia, porcine dermatitis and nephropathy 
syndrome (PDNS) and to reproductive problems (Allan et al., 2000; Allan and Ellis, 2000; Sanchez 
et al., 2001). Replication of PCV2 in lymphoid tissues can occurs in B and T lymphocytes, 
monocytes and macrophages and in pigs affected with PMWS lymphocyte depletion and infiltration 
of monocytes in lymphoid tissues have been observed (Chianini et al., 2003; Sanchez et al., 2004; 
Yu et al., 2007). 
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A novel type of porcine circovirus, named porcine circovirus type 3 (PCV3), was described for the 
first time in November 2016 in USA (Phan et al., 2016) and has subsequently also been detected in 
Asia and Europe including Denmark (Franzo et al., 2018; Ku et al., 2017; Stadejek et al., 2017). 
PCV3 is genetically quite different from PCV2, since the two viruses only share 50% similarity. 
Currently, the knowledge about PCV3 is based on only a few studies, thus future analyses are 
needed to clarify the prevalence and disease history of this novel virus.  
 
2.2.1.3 Porcine parvovirus 
Porcine parvovirus (PPV) belongs to the family Parvoviridae and is a small non-enveloped virus 
with a linear genome of single-stranded DNA. PPV, which occurs as a single serotype, is found in 
pig herds throughout the world, where it is enzootic in many of the herds, although the impact of 
disease has been substantially reduced by vaccination. The virus is an important cause of 
reproductive failure in pigs and infection with PPV can lead to stillbirth, mummification, embryonic 
death and infertility (SMEDI). The virus can replicate in different tissues and organs, including 
lymph nodes, tonsils, thymus, salivary glands, spleen and lungs, and, furthermore, it replicates well 
in blood lymphocytes, monocytes and macrophages. PPV infection of older pigs often causes only 
mild or subclinical disease, however, in rare cases the virus has also been associated with 
respiratory, vesicular and systemic disease of neonates. The major impact of PPV is infection of 
pregnant gilts and sows and the stage of gestation at which infection occurs determines the 
particular clinical signs observed. Infection of embryos in the first weeks of life results in death and 
resorption, while infection later in the gestation, but before day 70, results in dead of the foetuses, 
which can become mummified. Foetuses infected after 70 days of gestation are usually less affected 
due to development of an immune response (immune competence of pig foetuses starts at 60–70 
days) (Huysman et al., 1992; Mengeling et al., 2000; Woods and McDowell, 2009).  
 
2.2.1.4 Porcine reproductive and respiratory syndrome virus 
Porcine reproductive and respiratory syndrome virus (PRRSV) is a small, enveloped, single-
stranded RNA virus, which belongs to the family Arteriviridae and the genus Rodartevirus 
(Conzelmann et al., 1993; Kuhn et al., 2016; Meulenberg et al., 1993). The syndrome is 
characterized by reproductive failure in sows and respiratory disease in piglets and the virus is 
enzootic in pig herds throughout the world (Rossow, 1998).  Two genotypes of PRRSV exists and 
genomic sequence analysis shows that there are only around 63 % nucleotide identity between 
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viruses isolated in Europe and in North America (Allende et al., 1999). Today, the viruses 
previously classified as European type are now classified as Type 1 and those previously classified 
as North America type as Type 2. Both types are distributed worldwide (Shi et al., 2010). Infection 
with PRRSV can occur through different routes, but the most frequent route is the respiratory route, 
where PRRSV targets and replicates in macrophages in the alveolar and lymphoid tissue  
(VanReeth, 1997). Clinical signs induced by a PRRSV infection vary according to the age and 
pregnancy status of the infected pig (Rossow, 1998). PRRSV infection of a breeding herd can leads 
to reproductive failure, which can result in abortion, early farrowing, an increase in the number of 
stillborns, mummified foetuses and weak neonatal piglets (Figure 4). Furthermore, PRRSV 
infection in weaned and growing pigs is characterized by anorexia, fever, lethargy and pneumonia, 
while respiratory distress and preweaning mortality are features of the disease in neonatal pigs. The 
clinical signs observed depend on the level of virulence of the infecting strain (Rossow, 1998; 
Zimmerman et al., 1997).     
 
 
Figure 4 Mummified foetuses. Photo by Lise K. Kvisgaard. 
 
2.2.1.5 Swine influenza A virus 
swIAV is a respiratory infection caused by multiple subtypes of IAV, of which the predominant 
subtypes are H1N1, H1N2 and H3N2 and these viruses are enzootic in pigs worldwide. SwIAV 
infection starts in the upper respiratory tract by infection of the nasal, tracheal, and bronchial 
epithelium with eventually spread to the lung. The infection can be very acute, affecting most of the 
respiratory tract within only a few hours. Nasal virus shedding and virus replication in the lungs are 
short-lasting and limited to the first six or seven days after infection (Brown et al., 1993; De 
Vleeschauwer et al., 2009). The main symptoms of swine influenza are sudden onset of the disease, 
fever, lack of appetite, coughing, sneezing, nasal discharge, dyspnoea, exhaustion and abortion. The 
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severity of disease ranges from subclinical to acute and this is influenced by the infecting virus 
strain and the pig’s immunity. The morbidity within an affected herd is often high, while the 
mortality is usually low but it depends on the virus strain and other factors such as mixed infections 
and age (Zell et al., 2013). 
 
2.2.2 Pathogenesis and clinical signs of bacterial infections  
2.2.2.1 Actinobacillus pleuropneumoniae 
Actinobacillus pleuropneumoniae is a Gram-negative bacterium belonging to the Pasteurellaceae 
family and the genus Actinobacillus. A. pleuropneumoniae is classified into 18 serotypes, in which 
serotype 17 and 18 are currently recognized (Bossé et al., 2002; Gottschalk, 2015; Sárközi et al., 
2015). All serotypes can cause disease, but difference in virulence exists and the prevalence of the 
different serotypes differs across the world. A. pleuropneumoniae is the causative agent of porcine 
pleuropneumonia and the disease is distributed in pig worldwide, affecting pigs in all ages (Chiers 
et al., 2010). The lower respiratory tract is the site where A. pleuropneumoniae causes tissue 
damage leading to clinical disease. Clinical signs of acute disease are anorexia, coughing, 
depression, dyspnoea, fever and in worst case the disease can lead to death. However, A. 
pleuropneumoniae can also be present in a subclinical form, in which the bacteria resides in the 
respiratory tract and tonsillar tissue of carrier pigs (Chiers et al., 2002). A. pleuropneumoniae binds 
to mucus, proteins and cells of the lower respiratory tract and several virulence factors like fimbriae 
and lipopolysaccharides may play a role in its adhesion (Belanger et al., 1990; Bertram, 1990). The 
bacterium produces four toxins designated ApxI-IV, which belong to the pore-forming RTX toxin 
family (Frey et al., 1993; Schaller et al., 1999). These toxins are the most significant virulence 
factors produced by the A. pleuropneumoniae and together they play an important role during the 
pathogenesis of the infection (Chiers et al., 2010). 
 
2.2.2.2 Bordetella bronchiseptica  
Bordetella bronchiseptica is a Gram-negative bacterium belonging to the family Alcaligenaceae 
and the genus Bordetella. B. bronchiseptica is widely distributed in pig herds throughout the world 
and is one of the microorganisms, associated with the complex aetiology of atrophic rhinitis 
(Collings and Rutter, 1985). In atrophic rhinitis cases where B. bronchiseptica is alone, only a mild 
form of disease will occur, while in herds where both B. bronchiseptica and Pasteurella multocida 
are present severe atrophic rhinitis can occur, which can lead to severe distortion and atrophy of the 
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turbinate bones in the nasal terminus. Clinical signs observed by B. bronchiseptica infections are 
fleas from eyes and nose and sneezing (Chanter et al., 1989; Giles et al., 1980). B. bronchiseptica 
binds to the mucous membranes in the upper respiratory tract and several virulence factors like 
adhesions and toxins may play a role in the infection (Goodnow, 1980).  
 
2.2.2.3 Haemophilus parasuis  
Haemophilus parasuis is a Gram-negative bacterium belonging to the family Pasteurellaceae and 
the genus Haemophilus (Biberstein, E L; White, 1969). H. parasuis is present in pig herds 
worldwide and it is the causative agent of Glässer’s disease, which is characterized by fibrinous 
polyserositis, polyarthritis and meningitis (Amano et al., 1994; Olvera et al., 2006). H. parasuis is 
commonly isolated from nasal cavities, tonsils and the upper part of trachea from both healthy and 
diseased pigs. Infections with H. parasuis are occasional and the clinical disease particularly affects 
young pigs exposed to a stressful environment (Smart et al., 1989). Clinical signs as coughing, 
fever, reduced feed intake, lameness, convulsions and septicaemia are features observed with H. 
parasuis infections (Nedbalcova et al., 2006). To date, 15 serovars of H. parasuis have been 
defined, with apparent differences in virulence ranging from highly virulent to non-virulent 
(Kielstein and Rapp-Gabrielson, 1992). Virulence factors like lipo-oligosaccharides, fimbriae and 
toxins among others play a critical role in the pathogenesis of H. parasuis, however, the precise 
functions of these factors remains to be fully elucidated (Zhang et al., 2014). 
  
2.2.2.4 Mycoplasma hyopneumoniae 
Mycoplasma hyopneumoniae is a small bacterium that belongs to the family Mycoplasmataceae and 
the genus Mycoplasma. M. hyopneumoniae is present in pig herds worldwide and it is the causative 
agent of enzootic pneumonia, a disease characterized by high morbidity but low mortality. Pigs at 
all ages are susceptible to enzootic pneumonia and the condition is characterised by a dry and non-
productive cough, retarded growth rate and respiratory distress (Dubosson et al., 2004; Thacker, 
2004). M. hyopneumoniae adhere to the cilia of the respiratory epithelium, causing ciliary damage, 
clumping and loss of cilia and epithelial cell death. This results in diminished function of the 
mucociliary apparatus and thereby a weaker airway defence, which can pave the way for secondary 
infections (DeBey and Ross, 1994). 
 
 
Background  
 22 
2.2.2.5 Mycoplasma hyorhinis 
Mycoplasma hyorhinis is a small bacterium that belongs to the family Mycoplasmataceae and the 
genus Mycoplasma. M. hyorhinis is present in pig herds worldwide and it adheres to the mucosa of 
the upper respiratory tract and tonsils. The main clinical disorders associated with M. hyorhinis 
infections are polyserositis and arthritis, while pneumonia and otitis have also been observed. The 
first clinical signs of infection are sneezing and a clear watery nose fleece, which subsequently will 
assume a more inflammatory appearance. Normally, the disorder is harmless to the infected 
animals. Pigs of various ages can be infected but pigs below ten weeks of age are often more prone 
to infection (Kobisch and Friis, 1996; Thacker and Minion, 2012). 
 
2.2.2.6 Pasteurella multocida 
Pasteurella multocida is a Gram-negative bacterium belonging to the family Pasteurellaceae and 
the genus Pasteurella. P. multocida is classified into five serogroups (A, B, D, E and F) and 16 
serotypes based on the capsule and lipopolysaccharide antigens, respectively (Carter, 1955; 
Heddleston et al., 1972). P. multocida is found in pigs where it is associated with pneumonia and 
progressive atrophic rhinitis (PAR). Toxin (PMT) producing strains of P. multocidia cause PAR, 
which is characterized by atrophy of the nasal turbinate bones which, in severe cases, can lead to 
facial distortion. Toxigenic strains associated with PAR are most frequently of serotype D (Davies 
et al., 2003; Nielsen et al., 1991). Clinical signs observed with P. multocida infection are coughing, 
fever, sneezing, septicaemia, inflammation of the nasal mucosa and PAR (Davies et al., 2003). P. 
multocida binds to the mucosae of the upper respiratory tract in pigs and several virulence factors 
like toxins, hemagglutinins, fimbriae, lipopolysaccharides and capsules among others may play a 
role in the outcome of infection (Okay and Kurt Kizildoğan, 2015). 
 
2.2.2.7 Streptococcus suis 
Streptococcus suis is a Gram-positive bacterium that belongs to the family Streptococcaceae and 
the genus Streptococcus. S. suis is found in pig herds worldwide and is associated with arthritis, 
bronchopneumonia, meningitis and septicaemia in pigs in all ages (Higgins et al., 1990). Clinical 
signs depend on the pathogenesis of the disease, but symptoms such as anorexia, depression, fever, 
lassitude, convulsions, incoordination, opisthotonos and tremors have been observed (Staats et al., 
1997). To date, 35 serotypes of varying virulence have been described, where serotype 2 is the most 
prevalent type isolated from diseased pigs (Goyette-Desjardins et al., 2014; Aarestrup et al., 1998). 
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The natural habitat of S. suis is the mucosal surfaces in the upper respiratory tract particular the 
tonsils and nasal cavities. S. suis is a successful colonizer in pigs and pigs can harbour S. suis 
without showing clinical signs, which thereby acts as a reservoir of this pathogen (Staats et al., 
1997). Sows carrying the bacterium can infect their litters leading to neonatal death or carrier 
animals. A number of virulence factors, which are mainly involved in adhesion, anti-phagocytosis, 
invasion and activation of inflammatory pathways have been described for S. suis. However, their 
role in the pathogenesis of infection has not yet been fully elucidated (Baums and Valentin-
weigand, 2009).  
 
2.3 Intestinal pig pathogens  
Enteric diseases are a common problem in modern pig production worldwide and can result in 
severe economic losses due to an elevated use of medication, growth retardation and increased 
mortality. Enteric diseases can be caused by different pathogens and some pathogens are known to 
cause disease in young pigs, while others are responsible for disease in older pigs. Stress factors 
like environmental, nutritional and psychological stress can also have an influence on the 
susceptibility of the pigs for getting sick by infection (Heo et al., 2013). Selected enteric disease 
causing pathogens with high impact in the Danish pig industry will be described in the following 
sections with focus on pathogenesis and clinical signs. 
 
2.3.1 Pathogenesis and clinical signs of virus infections 
2.3.1.1 Rotavirus A 
Rotavirus A is a non-enveloped, segmented, double-stranded RNA virus, that belongs to the family 
Reoviridae and the genus Rotavirus (Paul and Lyoo, 1993). Rotavirus A is endemic in pig herds 
throughout the world and the virus is associated with acute gastroenteritis, which is usually seen in 
young animals (Saif and Fernandez, 1996).  Rotavirus A infects and replicates in the mature 
enterocytes located in the mid and upper part of the villi in the small intestine, causing villous 
atrophy and leading to diarrhoea (Dewey et al., 2003; Lundgren and Svensson, 2001). Diarrhoea 
can be caused by several mechanisms including malabsorption that occurs secondary to the 
destruction of enterocytes and stimulation of the enteric nervous system, villus ischemia and 
secretory components (Lundgren and Svensson, 2003; Ramig, 2004). The incubation time for 
rotavirus A is usually less than 24 hours, and clinical signs observed are, besides diarrhoea, 
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dehydration, anorexia and depressed growth, but Rotavirus A can also cause subclinical infections 
especially in older pigs (Lundgren and Svensson, 2001; Woode et al., 1976). 
 
2.3.2 Pathogenesis and clinical signs of bacterial infections 
2.3.2.1 Brachyspira pilosicoli 
Brachyspira pilosicoli is a Gram-negative bacterium belonging to the family Brachyspiraceae and 
the genus Brachyspira. B. pilosicoli is found in the intestine and causes porcine intestinal 
spirochetosis, a milder form of colitis. B. pilosicoli binds to the epithelial cells on the colonic 
mucosa leading to cell shedding and oedema due to functional disruption. Clinical signs of disease 
include mucus-containing non-bloody diarrhoea, reduced feed conversion and depressed growth 
rates (Jensen et al., 2000). Infection with B. pilosicoli does not seem to be age dependent since it 
has been isolated from both nursery and finisher pigs and, furthermore, the bacterium can act both 
as a primary pathogen and as part of mixed infections together with other bacteria (Jacobson et al., 
2003; Pedersen et al., 2014; Thomson et al., 1998).  
 
2.3.2.2 Escherichia coli 
Escherichia coli is a Gram-negative bacterium that belongs to the family Enterobacteriaceae. 
Enterotoxinogenic E. coli (ETEC) is one of the E. coli strains, which can cause enteric disease. A 
characteristic of ETEC strains are the fimbrial adhesins, which allow attachment to mucosal 
surfaces in the intestine. ETEC expressing F4 (also known as K88) and F18 fimbrial adhesins (F4 
ETEC and F18 ETEC) can cause diarrhoea in pigs and they are responsible for post-weaning 
diarrhoea, while F4 ETEC is also associated with diarrhoea in newborn piglets (Frydendahl, 2002; 
Ojeniyi et al., 1994). F4 ETEC and F18 ETEC adhere with their fimbriae to the intestinal brush 
border to specific F4 and F18 receptors, respectively, and the susceptibility of pigs to these 
pathogens is determined by the presence of F4 and F18 receptors (Nguyen et al., 2017). Post-
weaning diarrhoea occurs a few weeks after weaning and clinical signs vary from a mild disease 
with inappetence to watery diarrhoea in severe cases, where suddenly dead also can occur. In 
general, diarrhoea and a bluish-red discolouration of the skin is observed with post-weaning 
diarrhoea (van Beers-Schreurs et al., 1992).  
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2.3.2.3 Lawsonia intracellularis 
Lawsonia intracellularis is a Gram-negative bacterium that is classified in the delta subdivision of 
the Proteobacteria (Mcorist et al., 1995). L. intracellularis is widespread in pig herds worldwide 
and it is an obligate intracellular bacterium that replicates in the enterocytes. The bacterium can 
cause proliferative enteropathy, which is a common disease of weaned pigs and it is characterized 
by thickening of the terminal ileum, caecum and colon mucosa as a result of adenomatous 
proliferation of immature enterocytes. The disease can be mild and self-limiting but sometimes it 
can cause persistent diarrhoea, reduction in weight gain, haemorrhagic enteropathy and sudden dead 
(Lawson and Gebhart, 2000; McOrist et al., 2006; Stege et al., 2004). L. intracellularis is primarily 
associated with diarrhoea in growers and finishers (Jacobson et al., 2003; Stege et al., 2000). 
 
2.4 Diagnostic methods for detection of veterinary pathogens  
Traditionally, laboratory diagnostics for detection of veterinary pathogens have relied on methods 
like culturing, visualizing and antibody and antigen detection. However, in the more recent decades, 
methods for detection of nucleic acid such as the polymerase chain reaction (PCR) have been 
developed for diagnostic use. In order for a method to be a reliable, accurate and useful diagnostic 
tool it should fulfil certain prerequisites including speed, simplicity, sensitivity, specificity, 
reproducibility and low cost (Deb and Chakraborty, 2012; Schmitt and Henderson, 2005).  
 
2.4.1 Sampling and sample types 
The chance of detecting a given pathogen depends largely on the correct collection of samples. A 
sample must be taken from an appropriate site on the animal and at the right time. The site from 
which the sample is collected is influenced by the knowledge of the pathogenesis of the suspected 
pathogen(s). The right time for pathogen detection is usually as soon as possible after the affected 
animal shows clinical signs, since at this time the pathogen load will be at its maximum. Samples 
should be sent to the laboratory as fast as possible after the collection, and furthermore, must be 
kept cold and stored in an appropriate media or buffer in relation to the suspected pathogen(s). 
 
The sample types collected depend on the animal. For living pigs, nasal swab, oral fluid, faecal, 
blood and air samples are the most typical types of sample. Additionally, tissue samples taken from 
the part of the body where lesions are observed can be used if the pig is dead. The type of sample 
also depends on the kind of diagnostics performed. Oral fluid and faecal samples are suitable when 
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conducting pen based or herd level diagnostics. By using these sample types, it is easy to obtain one 
sample per. pen, which (theoretical) should contain sample material from all the pigs in a pen. Oral 
fluid samples can be collected through a cotton rope placed in the affected pens. The pigs are 
allowed to chew on the rope for approximately 30 minutes, after which the oral fluid can be 
extracted from the cotton by twisting it in a plastic bag (Biernacka et al., 2016). Faecal samples can 
be collected from socks covering the boots of a person walking through the contaminated part of the 
pen, by which faecal matter will be collected on the socks (Figure 5) (Pedersen et al., 2015). Air 
samples, which are collected by an air sampler, are also useful in herd level diagnostics (Stark et al., 
1998). For single animal diagnostics, nasal swab and blood samples are suitable. However, with this 
kind of sampling the veterinarian needs to be in contact with each of the tested pigs to obtain the 
samples. Thus, this kind of sampling types can be more time consuming and expensive, depending 
on the number of sampled animals. Therefore, the choice of sample type should be based on clinical 
signs, on the knowledge of the pathogenesis of the suspected pathogen(s) and on the number of 
diseased animals.   
 
 
 
 
 
 
 
 
 
2.4.2 Classical methods – cultivation, antibody and antigen detection  
Some of the oldest diagnostic methods are cultivation-based methods, which are still used in many 
laboratories today. In recent years, these methods have been improved considerably with advances 
in the diversity of media components, use of heterologous hosts, use of organ culture and tissue 
explants, controlling of environmental conditions and use of growth-promoting factors. 
Consequently, cultivation-based methods have been useful in discovering and identifying new or 
unanticipated pathogens (Relman, 1999). Cultivation of pathogens are usually simple, however, it 
can be a time consuming process taking between two to three days before the initial results are 
Figure 5 Picture showing sampling of faeces (Pedersen et al., 2015). 
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verified through a confirmation process. In addition, the cultivation-based methods depend on the 
ability of the pathogen to grow in a medium (Zhao et al., 2014).  
     For antigen-based detection, methods like immunofluorescence and immunohistochemical 
staining and enzyme-linked immunosorbent assay (ELISA) are used. The big revolution within 
these methods came with the development of monoclonal antibodies, which are highly specific in 
their binding to antigen. Immunofluorescence and immunohistochemical staining relies on similar 
principles, in which the binding of an antigen to an agent-specific antibody is detected by the 
emission of light. For immunofluorescence staining, a fluorescent-labelled antibody is used, while 
an enzyme-labelled antibody is used in the immunohistochemical staining. In the ELISA test, the 
antigen is also recognized by an agent-specific antibody, and binding will result in a visible colour 
change. Here, the amount of antibody-antigen binding can be measured by a spectrophotometer. 
Furthermore, the availability of commercially ready-to-use ELISA kits for veterinary practices 
allows for a large number of samples to be analysed quickly. However, an important notion to make 
when using antigen detection methods is the fact that they are agent specific and since antigens can 
be altered due to e.g. mutations this can lead to loss of binding affinity and thereby to loss of test 
sensitivity because of false-negative results (Clarke and Casals, 1958; Donaldson, 2015; King et al., 
1997).      
     Detection of antibody responses can be a valuable test for defining the infection status of an 
animal. In this context, the antibody test can be used to determine whether an animal has suffered 
from any previous infections caused by a particular pathogen, to see if the animal has responded to 
a vaccination or to see if a specific pathogen is linked to a clinical event. Methods like ELISA, 
neutralisation and complement fixation can be used for antibody detection and in these methods 
serum antibody interacts with the agent of interest. In the ELISA test, the antibody-antigen 
interaction can be followed by the presence of a colour change due to the chemical reaction of an 
indicator enzyme, while in the neutralisation test the interaction is based on the presence of 
cytopathic effect on the cell culture. In the complement fixation test, a positive sample containing 
antibodies will result in non-haemolysis of the red blood cells due to fixation of the complement as 
a result of antibody-antigen interaction (Schmitt and Henderson, 2005). Furthermore, some viruses, 
including IAVs, have the ability to haemagglutinate and thereby, the haemagglutination inhibition 
(HI) test can be used for diagnosis of infection. Based on this test the HI titer, which is the highest 
dilution of serum that inhibits the agglutination of the red blood cells, can be found (Clarke and 
Casals, 1958). An antibody response should be considered in relation to the vaccination status of the 
Background  
 28 
animal, thus, sero-responses to vaccines should be distinguished from those that occur after a 
natural infection.  
 
2.4.3 Polymerase chain reaction (PCR) 
In recent years, the methodology used for analysing of veterinary samples has shifted to the use of 
molecular biology techniques, which allow characterization on the genome level. The molecular 
technique with the widest application in veterinary diagnostics is polymerase chain reaction (PCR) 
and the strength of this method is its ability to make millions of copies of a target gene (Schmitt and 
Henderson, 2005). PCR was developed in the 1980s and today it is one of the most used 
technologies in the world (Saiki et al., 1988). PCR is a highly sensitive and specific method that 
allows detection of a pathogen in a sample by detecting a specific stretch of nucleic acids. It 
operates by amplifying a specific gene sequence in a cyclic process by using a pair of synthetic 
oligonucleotide primers. The primers, which are usually about 18 to 22 residues long, are termed 
forward and reverse primer and these are complementary to the target DNA and define the region to 
be amplified. In the first step of PCR, the double-stranded target DNA is denatured at high 
temperature resulting in single-stranded DNA. This allows for the forward and reverse primers to 
anneal to the complementary sequence in the target DNA at a lower temperature. The annealing is 
followed by an elongation step in which the primers are extended in the presence of 
deoxynucleotides triphosphates (dNTPs) and a thermostable DNA polymerase, which adds the 
dNTPs complementary to the target sequence in the 5’ to 3’ direction. The primer extension 
products synthesized in one cycle will serve as templates in the next cycle and by repeating this 
thermal cycling between 35 to 45 times, the amount of target DNA will increase exponentially and 
millions copies of the target DNA will be obtained (Figure 6). PCR can also detect RNA sequences 
by using the method reverse transcription PCR (RT-PCR). RT-PCR contains a preliminary step 
where RNA is reverse transcribed into complementary DNA (cDNA) using a reverse transcriptase. 
The synthesized cDNA is then used as template for amplification in the PCR thermal cycling 
process. The amplified PCR product can be detected by agarose gel electrophoresis, stained with 
ethidium bromide, and visualized by UV light. In the agarose gel, the amplicons are separated based 
on size and this gel-based PCR method is termed conventional PCR (Freeman et al., 1999; 
Schochetman et al., 1988; Smith, 1996).  
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Figure 6 Schematic overview of polymerase chain reaction (PCR). 1) The double-stranded DNA template is denatured. 2) PCR 
primers anneal to the single-stranded DNA template. 3) The thermostable DNA polymerase elongates the PCR primers by addition 
of nucleotides resulting in a double-stranded product complementary to the target sequence. Figure obtained from (Nair, 2014).  
 
2.4.3.1 Quantitative real-time PCR  
In contrast to conventional PCR, in which the results are obtained at the end of the reaction, 
quantitative real-time PCR (qPCR) or reverse transcription qPCR (RT-qPCR) displays the data of 
amplification after each cycle. PCR becomes real-time by the addition of either a fluorescent dye or 
a fluorogenic probe. Fluorescent dyes, such as SYBR green I and EvaGreen, bind to the double-
stranded DNA, thereby emitting a fluorescent signal. There are several types of probe designs 
available, but the most common type is the dual-labelled probes, also known as hydrolysis probes. 
These probes, which anneals between the PCR primers, have a fluorescent reporter dye at the 5' end 
and a quencher at the 3' end and are typically between 20 to 30 nucleotides long. During elongation, 
the dual-labelled probe is hydrolysed by the 5´-3´exonuclease activity of the DNA polymerase, 
which cleaves the fluorescent reporter from the probe resulting in generation of a fluorescent signal 
(Figure 7). The fluorescent signal, emitted from both dye labelling systems, is detected at the end of 
each PCR cycle and as the number of amplicons increase during the qPCR reaction, the fluorescent 
signal also increases. The progression of the qPCR reaction is visualized by plotting the fluorescent 
signal against the cycle number giving rise to the amplification curve. Based on a defined threshold 
the quantification cycle (Cq) value, which is the cycle number at which the amplification curve for a 
given sample crosses the threshold, can be measured. A low Cq value indicates a high template 
concentration, while a high Cq value indicates a low template concentration. In qPCR, the targeted 
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nucleic acid concentration can be quantified either relative to a reference or to a set of standards 
used to construct a standard curve. A standard curve consisting of a series of samples with known 
amounts of target template can also be used to determine the performance of a qPCR assay in that it 
allows for estimation of the efficiency, detection of the assay dynamic range and limit of detection. 
By plotting the Cq values of the samples from the standard curve against the log10 of the sample 
concentrations, a linear curve with a negative slope is expected. Based on this plot, the efficiency 
can be calculated by the equation: efficiency = 10
(-1/slope)
-1. In theory, the amount of qPCR product 
is doubled after each cycle, which should yield an efficiency of 100%. However, both higher and 
lower efficiencies can be obtained, which can be caused by e.g. inhibitors of the qPCR or the lack 
of optimal prime/probe binding (Bustin et al., 2009; Svec et al., 2015).  
 
 
Figure 7 Schematic overview of quantitative real-time polymerase chain reaction (qPCR). Figure obtained from (Botes et al., 2013). 
      
Probe-based qPCR is the most common technology used in diagnostic analyses due to its higher 
specificity compared to dye-based qPCR, which can bind to any double stranded product, including 
primer-dimers, and with that can give rise to false-positive results. This problem can to some extent 
be remedied by a melting curve analysis, which can differentiate the target products from the 
primer-dimer formation. Probe-based qPCR is more expensive than dye-based qPCR due to the 
high cost of the probe. However, since the probe-based assay allows sequence specific binding and 
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thereby eliminates false-positive results this type of assay is preferred in many contexts (Law et al., 
2015; Peters et al., 2004).  
     Multiplexed qPCR or RT-qPCR tests that allows for simultaneous screening of several 
pathogens from a single sample is one of the newest tools developed within the recent years. In 
multiplex qPCR, several sets of specific primers and probes are used, while only one set of specific 
primers and probe are used in a “single” qPCR assay. Multiplex qPCR can be very useful in 
evaluation of samples from disease complexes like in cases with respiratory or reproductive 
problems in a pig herd (Xu et al., 2012). However, in order to produce a successful multiplex 
qPCR, it is important to be aware that the included assays have to be carried out under the same 
PCR conditions, which imposes certain design requirements of the primers and probes.  
 
2.4.3.2 High-throughput real-time PCR 
qPCR can also be performed in a high-throughput manner by using platforms in which a high 
number of different samples can be tested in a high number of different assays. The high-throughput 
qPCR BioMarkTM system from Fluidigm (South San Francisco, USA) is one of the available 
platforms on the market and represents a system capable of performing parallel qPCR reactions in a 
microfluidic manner. The reactions are carried out in Dynamic ArrayTM (DA) Integrated Fluidic 
Circuit (IFC) nanofluidic chips, which contain fluidic networks that automatically combine the 
samples with the assays (Figure 8). The BioMark dynamic array system allows its users to combine 
either 48 samples with 48 assays (48.48DA), 96 samples with 96 assays (96.96DA) or 192 samples 
with 24 assays (192.24DA) resulting in 2,304, 9,216 or 4,608 individual reactions, respectively, in a 
single run. The samples and qPCR reagents are loaded into appertaining inlets in the DA chip and 
by pressure these are distributed into the reaction chambers via microfluidic channels prior to the 
qPCR (Spurgeon et al., 2008). The high-throughput qPCR BioMark system has been widely used in 
research studies for years, including e.g. the study of innate immune response to IAV (Skovgaard et 
al., 2013). More recently, the system has also been used as a screening and detection tool for food- 
and waterborne pathogens and for tick-borne diseases (Ishii et al., 2013; Michelet et al., 2014).      
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2.4.4 Nucleic acid sequencing 
Nucleic acid sequencing technologies have brought insights and opportunities into understanding all 
types of biological phenomena including the diversity of veterinary pathogens. Sequencing is a 
process of determining the precise order of nucleotides within a DNA or RNA (cDNA) molecule. 
One of the first sequencing methods was the Sanger sequencing method, also known as dideoxy 
chain termination method, which was developed by Frederick Sanger in 1977 (Sanger et al., 1977). 
The principle behind the modem Sanger sequencing method relies on the use of fluorescent labelled 
nucleotides that have the ability to terminate primer-dependent elongation followed by high 
resolution gel separation of the fragments. The sequence of the template is determined based on the 
fragmentation and the emissions produced by the fluorescent dye labels, which are converted into 
nucleotide sequence information (Heather and Chain, 2016). Sanger sequencing is commonly used 
today due to its simplicity and ease of use, and this method is preferable when sequencing amplicon 
targets up to 1-500 base pairs and sequencing single genes due to the use of specific primers 
(Deurenberg et al., 2017). Over the last decades, next-generation sequencing (NGS) has evolved 
rapidly and with this method millions of fragments can be sequenced in a single run in contrast to 
Sanger sequencing which only produces one forward and reverse read. Today, a number of different 
NGS platforms using different sequencing technologies are available and properties like cost, 
Figure 8 48.48 Dynamic array IFC chip. Picture modified from the Fluidigm website. 
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output and fragment length are important factors for these. NGS allows sequencing of the whole 
genome of numerous pathogens in a single run without using target specific primers and it can 
sequence more than 100 genes simultaneously (Behjati and Tarpey, 2013). 
     Sequence analyses can be used to answer diagnostic questions such as the genetic relationship 
within pathogens and the detection of mutations in genomes, which can be important knowledge 
since mutations within a gene can lead to resistance against antibiotics or antivirals (Deurenberg et 
al., 2017). Alignments and phylogenetic analyses based on sequences of a specific pathogen or gene 
can contribute with indispensable information about the evolutionary relationship based on 
similarities and differences of the sequences. In addition, sequencing of the 16S rRNA gene is 
commonly used to study the phylogeny and taxonomy of bacteria (Janda and Abbott, 2007).  
 
2.4.5 Point of care diagnostics 
Point of care (POC) diagnostics has attracted increased attention in the recent years. POC testing 
has the advantage that immediate results can be obtained since the test is carried out on site or near 
to the site of the animal (St-louis, 2000). Thereby, it is not necessary to send the samples to the 
laboratory for analysis and await the results, which can take hours or days. The use of POC testing 
for diagnostics is also interesting due to the potential of decreasing cost and reduction in the time 
between sampling and results, allowing for a faster treatment decision. Several POC devices have 
been developed and different technologies have been used. Some of the currently available 
veterinary POC tests offer cost-effective and decentralised diagnosis of a wide range of infectious 
diseases, however, these tests come with some limitations. In general, the analytical performances 
of several POC tests are still considered limited compared to laboratory-based testing, but the use of 
microfluidic technology has brought new opportunities into the world of POC diagnostics (Busin et 
al., 2016).  
 
2.4.6 Interpretation of laboratory findings   
It is crucial that results obtained by analytical methods are accurate and reliable, since diagnoses 
and treatments are based on results obtained by these methods. False-positive and false-negative 
results can occur in many tests and therefore, the inclusion of positive and negative controls is 
important in every single test. Rapid detection methods, which are highly sensitive and specific are 
important in the veterinary industry to prevent outbreaks of diseases and the spread of pathogens. 
Furthermore, sensitivity is important since a single copy of a pathogen present has the risk to cause 
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infection. Methods get more and more sensitive resulting in the ability to detect latent and low level 
persistent infections, which do not always necessarily result in disease. Therefore, interpretation of 
the results obtained by these very sensitive methods should be taken with care. Additionally, high 
specificity is important to be able to differentiate between different pathogen species and between 
very similar pathogens. For detection of a specific pathogen, the use of one method can be 
sufficient, while combination of several methods is necessary in other cases depending on the type 
of pathogen and on the purpose of the detection. Each method has its own advantages and 
limitations, which should be seen in relation to the use of the specific method.  
 
Own studies  
 35 
3 Own studies 
Own studies – Manuscript I 
 36 
3.1 Manuscript I 
 
Subtyping of swine influenza viruses using a high-throughput real-time PCR 
platform 
 
Nicole B. Goecke
1*
, Jesper S. Krog
1
, Charlotte K. Hjulsager
1
, Kerstin Skovgaard
1
, Timm C. 
Harder
2
, Solvej Ø. Breum
1
, Lars E. Larsen
1 
 
1
National Veterinary Institute, Technical University of Denmark, Kgs. Lyngby, Denmark 
2
Institute of Diagnostic Virology, Friedrich-Loeffler Institute, Greifswald-Insel Riems, Germany 
 
*Corresponding author: Nicole B. Goecke, nicbg@vet.dtu.dk 
 
 
 
 
Published in  
Frontiers in Cellular and Infection Microbiology, 2018; 8: 165 
doi: 10.3389/fcimb.2018.00165  
Own studies – Manuscript I 
 37 
 
Own studies – Manuscript I 
 38 
 
Own studies – Manuscript I 
 39 
  
Own studies – Manuscript I 
 40 
 
Own studies – Manuscript I 
 41 
 
Own studies – Manuscript I 
 42 
 
Own studies – Manuscript I 
 43 
 
Own studies – Manuscript I 
 44 
  
Own studies – Manuscript I 
 45 
  
Own studies – Manuscript I 
 46 
 
Own studies – Manuscript I 
 47 
  
Own studies – Manuscript I 
 48 
Own studies – Manuscript I 
 49 
Own studies – Manuscript II 
 50 
3.2 Manuscript II 
 
Development of a high-throughput real-time PCR system for diagnosis of 
enzootic pathogens in pigs 
 
Nicole B. Goecke
1*
, Charlotte K. Hjulsager
1
, Jesper S. Krog
1
, Kerstin Skovgaard
2
, Lars E. Larsen
1 
 
1
National Veterinary Institute, Technical University of Denmark, Kgs. Lyngby, Denmark 
2
Bioengineering, Technical University of Denmark, Kgs. Lyngby, Denmark 
 
*Corresponding author: Nicole B. Goecke, nicbg@vet.dtu.dk 
 
 
 
 
 
(Prepared for submission) 
 
 
  
Own studies – Manuscript II 
 51 
Abstract  
Respiratory and intestinal diseases in pigs can have significant negative influence on the 
productivity and animal welfare. The diagnostic laboratory at the National Veterinary Institute in 
Denmark analyses thousands of samples each year for the presence of porcine pathogens. Presently, 
a wide range of different quantitative real-time polymerase chain reaction (qPCR) assays are used 
for the pathogen detection and the PCR analyses are performed on traditional real-time PCR 
platforms, in which a limited number of samples can be analysed per day due to limitations in 
equipment and personnel. To mitigate these restrictions, the qPCR assays have been optimised for 
the high-throughput qPCR BioMark platform (Fluidigm). The BioMark platform uses an integrated 
fluidic circuit (IFC) technology to prepare and perform qPCR reactions in nanoliter volumes and it 
is capable of performing up to 9,216 parallel reactions in a single run. Using this platform, we have 
developed a high-throughput diagnostic system, which can be used for simultaneous examination of 
48 samples with detection specificity for 17 selected respiratory and enteric viral and bacterial 
pathogens of high importance to the Danish pig production. qPCR assays were validated and 
optimized to run under the same reaction conditions using a BioMark 48.48 dynamic array 
(48.48DA) IFC chip and the sensitivity and specificity were assessed by testing known positive 
samples. The results revealed a performance of the diagnostic 48.48DA similar to traditional qPCR 
analysis, and the specificity of the diagnostic 48.48DA was high. Application of the high-
throughput platform results in a significant reduction in cost and working hours and provides 
production herds with a new innovative diagnostic service with the potential to facilitate the optimal 
choice of disease control strategies such as vaccination and treatment. 
 
Keywords 
Respiratory porcine pathogens, enteric porcine pathogens, diagnostics, high-throughput, real-time 
PCR.    
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Introduction 
Respiratory and intestinal diseases are of major importance in the commercial pig production 
throughout the world as these diseases can result in major economic losses due to reduced 
productivity, decreased animal welfare, increased mortality or morbidity and increased use of 
antibiotics. The cause of disease can either be single- or multifactorial. The prevalence and 
combination of pathogens can fluctuate between countries and herds, and the composition of 
pathogens can change over time due to e.g. change in management, environmental changes, season 
and stage of infection (Hansen et al., 2010; Heo et al., 2013; Hernandez-Garcia et al., 2017; 
Opriessnig et al., 2011; Stärk, 2000).  
     Pathogens involved in the porcine respiratory disease complex (PRDC) include bacteria such as 
Actinobacillus pleuropneumoniae, Bordetella bronchiseptica, Haemophilus parasuis, Mycoplasma 
hyopneumoniae, Mycoplasma hyorhinis, Pasteurella multocida and Streptococcus suis. Viral agents 
of PRDC includes porcine circovirus type 2 (PCV2), porcine cytomegalovirus (PCMV), porcine 
reproductive and respiratory syndrome virus (PRRSV) and swine influenza A virus (swIAV). Many 
of the respiratory pathogens are ubiquitous and it is not uncommon for multiple pathogens to 
circulate in a herd at any given time without causing disease (Brockmeier et al., 2002; Harms et al., 
2002; Kim et al., 2003; Opriessnig et al., 2011; Phan et al., 2016; Thacker et al., 2001). However, 
the respiratory pathogens may also cause clinical symptoms such as depression, anorexia, fever, 
slight nasal and ocular discharge, cough, slight hyperpnoea and even fatal pneumonia (Janke, 1995; 
Opriessnig et al., 2011; Thacker, 2001).  
     Intestinal diseases can be induced by a number of different viruses, bacteria and parasites, and 
are also considered as a multifactorial problem. Diarrhoea together with dehydration, reduced feed 
intake, reduced growth and reduced nutrient digestibility are symptoms associated with intestinal 
disorders (Fouhse et al., 2016; Heo et al., 2013; Jacobson et al., 2003). Some of the most frequently 
found bacteria associated with intestinal disease in Danish pigs are Lawsonia intracellularis, 
Brachyspira pilosicoli and Escherichia coli fimbria types F4 and F18 (Jacobson et al., 2003; 
Pedersen et al., 2014; Weber et al., 2015). Viruses such as rotavirus A and PCV2 may also 
contribute to enteric disease. Rotavirus A is a known diarrhoea causing agent in pigs (Bohl et al., 
1978), while PCV2 has not been proven to be a primary cause of diarrhoea in pigs but systemic 
PCV2 may, however, indirectly contribute to enteric diseases due to its immunosuppressive effect 
(Jensen et al., 2006; Johansen et al., 2013; Segalés, 2012). Coronaviruses such as transmissible 
gastroenteritis virus, porcine deltacoronavirus and porcine epidemic diarrhoea virus can also induce 
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enteric diseases, but Denmark and many other European countries are free of these viruses 
(Pensaert and Martelli, 2016). 
     The choice of suitable control measures such as vaccination and antibiotic treatment are often 
based on clinical manifestations without support from laboratory investigations. This may lead to 
overuse of antibiotics and suboptimal vaccination programs. The diagnostic laboratory of the 
National Veterinary Institute, Technical University of Denmark, analyses thousands of samples 
each year for the presence of pathogens in Danish pigs. Today, a wide range of different 
quantitative real-time polymerase chain reaction (qPCR) assays are used for the pathogen detection 
and the analyses are performed on traditional or so-called low-throughput qPCR platforms. A major 
bottleneck of these platforms is the limited number of different targets that can be tested at the same 
time, and furthermore, these qPCR analyses are expensive and resource demanding, both when it 
comes to reagents and working time (wage cost). Thus, there is a need for the development of faster 
and cheaper diagnostic systems. 
The aim of the present study was to develop a high-throughput qPCR detection system capable of 
detecting significant porcine viruses and bacteria in the same setup. For this, the microfluidic high-
throughput qPCR BioMark platform (Fluidigm, South San Francisco, USA), which can perform 
parallel qPCRs, was utilized. The BioMark dynamic array (DA) system (Fluidigm) is able to 
combine e.g. 48 samples with 48 assays or 96 samples with 96 assays or 192 samples with 24 
assays in a combinatorial manner inside the integrated fluidic circuit (IFC) resulting in either 2,304, 
9,216 or 4,608 individual reactions in a single run (Liu et al., 2003). The present study describes the 
design, optimization and validation of a diagnostic 48.48DA; a setup consisting of 21 qPCR assays 
targeting 17 selected respiratory and enteric viral and bacterial pathogens of high importance in the 
Danish swine industry.  
 
Materials and methods 
Samples 
Known positive samples (controls) for each of the 17 selected pathogens were used for optimization 
and initial validation of the diagnostic 48.48DA. The positive controls consisted of cell culture 
lysates (viruses), pure bacterial cultures, vaccine strains and plasmids. Furthermore, 91 field 
samples (oral fluid, faecal sock, lung tissue and liver tissue samples), from routine submissions to 
the National Veterinary Institute, were used for validation of the diagnostic 48.48DA. These 
samples came from pig herds with a history of respiratory or intestinal disease and had been tested 
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in the routine diagnostic setting at the Danish National Veterinary Institute for presence of 
pathogen(s). 
 
RNA and DNA extraction 
Viral RNA was extracted from cultured viruses, oral fluid, lung tissue or nasal swab samples by the 
RNeasy Mini Kit (QIAGEN) according to the manufacturer’s instructions using the large sample 
protocol version 2 on the QIAcube (QIAGEN) extraction robot. Cell culture supernatant, oral fluid 
and nasal swab samples were prepared by mixing 200 µL material with 400 µL RLT buffer 
containing β-mercaptoethanol (Sigma-Aldrich). Lung tissue samples were prepared by 
homogenization of 70 mg lung tissue in 1400 µL RLT buffer containing β-mercaptoethanol (Sigma-
Aldrich) on a TissueLyser II (QIAGEN) at 30 Hz in 3 min. The homogenate was centrifuged for 3 
min at 12,000 g, and RNA was extracted from 600 µL of the supernatant. Viral RNA was eluted in 
60 µL RNase-free water and stored at -80°C. 
 
Viral and bacterial DNA were extracted from oral fluid, lung tissue or liver tissue samples by the 
QIAamp DNA Mini Kit (QIAGEN) according to the manufacturer’s instructions using the tissue 
standard protocol version 1 on the QIAcube (QIAGEN) extraction robot. Oral fluid samples were 
prepared by centrifugation of 200 µL sample at 1,000 rpm for 3 min, followed by a tenfold dilution 
in nuclease free water. Lung and liver tissue samples were prepared by homogenization of 180 mg 
lung tissue in 1300 µL ATL buffer on a TissueLyserII (QIAGEN) in 3 min. The homogenate was 
centrifuged for 3 min at 12,000 g, and 200 µl of the supernatant was mixed with 20 µl Proteinase K 
and incubated for 10 min at 56C. DNA was eluted in 200 µL Buffer AE and stored at -20°C. 
 
10% faeces in PBS samples were extracted using the QIAsymphony SP system (QIAGEN) 
extraction robot and QIAsymphony DSP virus/pathogen mini kit (QIAGEN) following the 
manufacturer’s instructions. The protocol was Complex200_V5_DSP with an elution volume of 
110 µL. Before extraction, one 5 mm steel bead was added to each sample and the samples were 
homogenized in a Tissuelyser II (QIAGEN) for 20 sec at 15 Hz. The homogenate was then 
centrifuged for 90 sec at 10,000 rpm and the 350 µL of the supernatant was used for nucleic acid 
extraction. The nucleic acid extractions were stored at -80°C until further analysis.    
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Primer and probe design 
The diagnostic 48.48DA was designed to include 21 qPCR assays primarily targeting respiratory 
and enteric viral and bacterial pathogens using the sets of primers and probes listed in Table 1 and 
2. The primer and probe sequences were either from previously published assays or designed for the 
present study. Some of the published primer and probe sequences were slightly modified to improve 
their specificities, and the fluorophore and/or quencher were changed for some of the assays as 
well. These modifications are highlighted in bold in Table 1 and 2. Furthermore, for the PCV2 and 
PPV assays the detection chemistry was changed from Primer Probe Energy transfer to dual 
labelled probe chemistry to match the remaining assays. New primer and probe sequences were 
designed based on alignments comprising full-length or nearly full-length sequences of target gene 
for the selected pathogen. Sequences used for the alignments were retrieved from GenBank (NCBI 
Resource Coordinators, 2017) and aligned using CLC Main Workbench version 7.7.3 
(https://www.qiagenbioinformatics.com/). Oligonucleotide specificity was tested in silico using 
BLAST search (Altschul et al., 1990), while melting temperature and basic properties of the 
oligonucleotides were approximated using OligoCalc (Kibbe, 2007). The primer and probe 
sequences were purchased from Eurofins Genomics (Ebersberg, Germany) and stored at -20°C. The 
sensitivity and specificity of each qPCR assay were validated based on a tenfold serial dilution 
range of positive controls (Table 3 and 4) on the Rotor-Gene Q qPCR system (QIAGEN, Hilden, 
Germany).  
 
Traditional qPCR on Rotor-Gene Q 
Assays targeting RNA viruses 
For the RNA targets, different master mixes and PCR conditions were tested during the initial 
validations. The RT-qPCR assay specific for Rotavirus A was performed in a final volume of 15 µl 
using AgPath-ID one-step RT-PCR reagents kit (Applied Biosystems, Foster City, USA) with 3 µL 
RNA. 7.5 µL RT-PCR buffer (2X) was mixed with 0.12 µL of each primer (50 µM), 0.18 µL probe 
(10 µM), 0.6 µL RT-PCR enzyme mix (25X) and nuclease free water. The thermal cycling 
conditions were 45°C for 10 min, 95°C for 10 min followed by 48 cycles at 95°C for 15 sec and 
60°C for 45 sec. The fluorescence signal was acquired at the 60°C step in the Green channel (470-
510 nm).  
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The RT-qPCR assay specific for swIAV was performed in a final volume of 25 µL using QIAGEN 
One-Step RT-PCR kit (QIAGEN), with 5 µL QIAGEN One-Step RT-PCR buffer (5X), 1 µL dNTP 
mix (10 mM), 1.25 µL MgCl2 (25 mM), 1 µL of each primer (100 µM), 0.25 µL probe (30 µM), 1 
µL QIAGEN enzyme mix, 2 µL RNA and nuclease free water. Thermal cycling conditions were: 
50°C for 30 min, 95°C for 15 min followed by 40 cycles at 94°C for 10 sec, 54°C for 30 sec and 
72°C for 10 sec. The fluorescence signal was acquired at the 54°C step in the Green channel (470-
510 nm).  
 
The PRRSV-specific RT-PCR assays were performed in a final volume of 25 µL using QIAGEN 
One-Step RT-PCR kit (QIAGEN) with 2 µL RNA. The mixes consisted of 5 µL QIAGEN One-
Step RT-PCR buffer (5X), 1 µL dNTP mix (10 mM each), 0.75 µL of each primer (10 µM), 0.50 
µL probe (10 µM), 1 µL QIAGEN enzyme mix and nuclease free water. The thermal cycling 
conditions were: 50°C for 30 min, 95°C for 15 min, followed by 45 cycles at 94°C for 15 sec, 60°C 
for 60 sec and 72°C for 10 sec. The fluorescence signal was acquired at the 60°C step in the Green 
channel (470-510 nm).  
Data obtained from each of the above mentioned assays were analysed with the Rotor-Gene Q 
Series Software 2.3.1 (QIAGEN) with the following parameter adjustments: dynamic tube 
normalization, on; noise slope correction, on; ignore first cycle; outlier removal, 10%; 
quantification cycle (Cq) threshold fixed, 0.01. All reactions were run in duplicates together with 
positive and negative controls. 
 
Assays targeting DNA viruses and bacteria 
For the DNA targets (except for PCV3), the qPCR assays were performed in a final volume of 25 µl 
using the JumpStart Taq ReadyMix (Sigma-Aldrich, St. Louis, USA) with 3 µL of DNA. The PCR 
mixes for L. intracellularis, B. pilosicoli, E. coli F4 and E. coli F18 were prepared as previously 
described by Ståhl et al., 2011 (Ståhl et al., 2011), while the PCR mixes for the remaining DNA 
targets contained 12.5 µL JumpStart Taq ReadyMix (2X), 0.75 µL of each primer (10 µM), 0.21 µL 
probe (30 µM), 3.5 µL MgCl2 (25 mM) and nuclease free water. All amplifications were run at the 
same cycling conditions: 94°C for 2 min followed by 40 cycles of 94°C for 15 sec and 60°C for 60 
sec. The PCV3 assay was performed in a final volume of 25 µL with 2.5 µL AmpliTaq Gold buffer 
(10x) (Applied Biosystems), 0.5 µL dNTPs (10 mM), 2.5 µL MgCl2 (25 mM), 0.75 µL of each 
primer (10 µM), 0.5 µM probe (10 µM), 0.25 µL AmpliTaq Gold DNA polymerase [5 U/µL] 
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(Applied Biosystems), nuclease free water and 3 µL DNA. The cycling conditions were: 94°C for 
10 min followed by 45 cycles at 94°C for 15 sec and 60°C for 60 sec, where the fluorescence signal 
was acquired at the 60°C step in the Green channel (470-510 nm). Data obtained from each of the 
above mentioned assays were analysed with the Rotor-Gene Q Series Software 2.3.1 (QIAGEN) 
with the following parameter adjustments: dynamic tube normalization, on; noise slope correction, 
on; ignore first cycle; outlier removal, 10%; threshold fixed, 0.01. All reactions were run in 
duplicates with positive and negative controls. 
 
Reverse transcription and pre-amplification prior to high-throughput qPCR 
A primer mix containing all the different set of primers (20 μM) listed in Table 1 and 2 was 
prepared. 
     For the RNA targets, reverse transcription and pre-amplification was performed in a final 
volume of 25 µL using the AgPath-ID one-step RT-PCR reagents kit (Applied Biosystems, Foster 
city, USA), in which 12.5 µL of 2X RT-PCR buffer was mixed with 1 µL 50 µM random hexamer 
(Invitrogen, Carlsbad, California, USA), 1.25 µL 20 µM primer mix, 1 µL 25X RT-PCR enzyme 
mix, 6.25 µL nuclease-free water and 3 µL RNA. One-tube combined reverse transcription and pre-
amplification was performed on a T3 Thermocycler (Biometra, Fredensborg, Denmark) with the 
following thermal cycling conditions: 20 min at 45°C, 10 min at 95°C followed by 24 cycles at 
94°C for 15 sec and 60°C for 45 sec. The pre-amplified cDNA was stored at -20°C. 
     For pre-amplification of the DNA targets, the TaqMan PreAmp master mix (Applied 
Biosystems) was used following the manufacturer’s instructions. The reaction was performed in a 
final volume of 10 µL containing 5 µL TaqMan PreAmp Master mix, 2.5 µL 20 µM primer mix and 
2.5 µL DNA. Pre-amplification was performed on T3 Thermocycler (Biometra) with the following 
thermal cycling conditions: 95°C for 10 min, followed by 14 cycles at 95°C for 15 sec and 60°C for 
4 min. The pre-amplified DNA was stored at -20°C. 
 
High-throughput qPCR 
For high-throughput qPCR amplification, the BioMark 48.48DA IFC chip (Fluidigm, South San 
Francisco, USA) was used. A 6 µL sample mix containing 3 µL TaqMan Gene Expression Master 
mix (Applied Biosystems), 0.3 µL 20X Sample Loading Reagent (Fluidigm) and 2.7 µL pre-
amplified sample was prepared for each sample. A primer/probe stock was prepared for each assay 
and 3 µL of the stocks was mixed with 3 µL 2X Assay Loading Reagent (Fluidigm) to make assay 
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mixes (final concentration: 16 µM primers and 5 µM probe). Prior to loading of the sample and 
assay mixes, the 48.48DA was primed in the IFC controller MX (Fluidigm). 4.9 µL sample mix and 
4.9 µL assay mix, for each of the samples and assays, were dispensed into the sample and assay 
inlets, respectively, on the 48.48DA. The 48.48DA was placed in the IFC controller MX for loading 
and mixing. After approximately 55 min, the 48.48DA was ready for thermal cycling in the high-
throughput qPCR instrument BioMark with the following cycling conditions: 94°C for 2 min, 
followed by 40 cycles of 94°C for 15 sec and 60°C for 60 s. Assays were performed in duplicates 
and samples were performed in single reactions. Three positive controls, containing a mix of all the 
positive controls included in the screening, two non-template controls (nuclease-free water, 
Amresco), a non-template cDNA/pre-amplification and a non-template pre-amplification controls 
(nuclease-free water, Amresco) were included in each 48.48DA chip as controls for non-specific 
amplification and sample contamination. 
     Data, including Cq values and amplification curves, were acquired on the BioMark system and 
analysed using the Fluidigm Real-Time PCR Analysis software 4.1.3 (Fluidigm). The amplification 
efficiency was calculated for each qPCR assay based on the slope of the standard curve, as 
previously described (Bustin et al., 2009). 
 
Validation of the diagnostic 48.48DA 
The sensitivity and specificity of the qPCR assays was validated by running tenfold serial dilution 
for each of the positive control samples (Table 1 and 2) on the diagnostic 48.48DA. The 
performance of the diagnostic 48.48DA was validated by testing 91 field samples (DNA/RNA 
extracted from oral fluid, faecal sock, lung tissue and liver tissue samples), which previously have 
been tested by RT-qPCR or/and qPCR on the Rotor-Gene Q platform in the diagnostic laboratory at 
the National Veterinary Institute, Denmark.  
 
Statistical analysis 
The correlation between the high-throughput qPCR BioMark platform and the Rotor-Gene Q 
platform was investigated using Pearson correlation coefficient (PCC) and the associated p-value 
(Benesty et al., 2009). The analyses were performed using the analysis tool Regression Statistics in 
Microsoft Excel 2010.  
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Results 
Specificity of the qPCR assays 
Primer and probe sequences were designed to specifically detect seven viruses and ten bacteria 
species (Table 1 and 2). Viral RNA and DNA and bacterial DNA extracted from known positive 
samples were used as positive controls to evaluate the specificity of the different qPCR assays 
included on the diagnostic 48.48DA. Initially, the positive controls were run on the diagnostic 
48.48DA without pre-amplification resulting in a lack of detection by the BioMark system for the 
majority of the samples. Consequently, an initial step of pre-amplification was added to the setup, 
which enabled the detection of all positive controls. The specificity of each qPCR assay was 
assessed from the Cq value and the corresponding amplification curve obtained from their 
respective positive control. For all the qPCR assays, specific positive reactions were registered, 
however, the assay specific for PPV cross reacted with the PPRSV type 1 positive control (Figure 
1). Theoretically, this cross reaction could be due to lack of specificity or co-infection of the 
sample, but since the positive control for PRRSV type 1 was a vaccine strain, the cross reaction 
may be explained by the lack of specificity.   
 
Sensitivity of the qPCR assays 
The PCR efficiencies for the Rotor-Gene Q platform and the BioMark platform ranged from 89-
107% and 85-110%, respectively (Table 3). To evaluate the sensitivity of the qPCR assays, series of 
tenfold diluted RNA and DNA of the positive controls were initially tested on the Rotor-Gene Q 
platform. Hereafter, the same dilutions of RNA and DNA were reverse transcribed/pre-amplified 
and pre-amplified, respectively, and tested on the BioMark platform. Comparison of the standard 
curves generated from the two platforms revealed that the dynamic range of the qPCR assays was 
either identical or had one log10 difference (Table 3), except for the assay specific for A. 
pleuropneumoniae. For A. pleuropneumoniae, the undiluted and the first diluted sample were 
excluded from the calculation of the effectivity (BioMark platform) due to too low Cq values. This 
exclusion resulted in a shorter dynamic range compared to the dynamic range for the dilution series 
analysed by the Rotor-Gene Q platform. For few of the assays the undiluted sample was not tested 
due to insufficient amount of available sample material.  
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Test of field samples on the diagnostic 48.48DA 
In order to test the performance of the diagnostic 48.48DA and to validate the system, 91 field 
samples (oral fluid, faecal sock, lung tissue and liver tissue samples), which had previously been 
analysed by RT-qPCR/qPCR on the Rotor-Gene Q platform in the routine diagnostic laboratory at 
the National Veterinary Institute, were tested on the diagnostic 48.48DA and the results were 
compared. In general, the Cq values obtained by the diagnostic 48.48DA was lower than the Cq 
values obtained at Rotor-Gene Q platform, which is expected due to the additional pre-amplification 
step. Thirty-six faecal sock samples, previously tested for L. intracellularis, B. pilosicoli and E. coli 
F4 and E. coli F18 using the Rotor-Gene Q platform, were tested on the diagnostic 48.48DA. 
Almost identical results were achieved for the faecal sock samples on the two platforms and thus, 
the correlation between the two platforms was found to be significant for all four assays (p < 0.05) 
(Table 4). However, the outcome for four of the samples differed (marked with red in Table 4). 
Three of these samples were found to be positive in one assay in the Rotor-Gene Q test, but 
negative in the same assay on the diagnostic 48.48DA, while the last sample was found to be 
positive in the diagnostic 48.48DA test, but negative in the Rotor-Gene Q test.  
     Fourteen oral fluid samples, of which five of the samples were positive for PCV2 and nine of the 
samples were positive for swIAV on the Rotor-Gene Q platform, were also tested on the diagnostic 
48.48DA. Here, the same five and nine samples were tested positive for PCV2 and swIAV, 
respectively (data not shown). Furthermore, 38 lung tissue samples, which had previously been 
analysed for other respiratory pathogens were also tested on the diagnostic 48.48DA. Comparisons 
of the results obtained by the two qPCR platforms are listed in Table 5. In general, the two 
platforms gave similar results, however, for the P. multocida analysis, the results for seven of the 
samples did not match. Six of these samples were found to be either negative or only slightly 
positive (denoted by low in table 5) in the analysis performed by the Rotor-Gene Q platform. The 
diagnostic 48.48DA analysis found the samples that were negative by the Rotor-Gene analysis to be 
positive, but with a relative high Cq value, and it found the slightly positive samples to be negative. 
The last sample (1991-3) of the seven was found to be present massively positive (Cq value < 25), 
but was negative on the diagnostic 48.48DA. Two differences were observed for a negative and a 
slightly positive M. hyorhinis sample. Furthermore, of the two PRRSV type 2 positive samples 
(455-5 and 455-6) the diagnostic 48.48DA analysis only found one (455-5) of these samples to be 
positive. However, the Cq value for sample 455-6 was 31.2, and this relative high value can be the 
reason why the sample was not detected by the diagnostic 48.48DA. The results obtained for the 
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qPCR assays specific for A. pleuropneumoniae and M. hyopneumoniae were 100% identical for the 
two platforms. In addition to the respiratory and enteric samples, three foetal liver tissue samples, 
which had been tested positive for PPV were also tested on the diagnostic 48.48DA and was found 
to be highly positive (Cq 3-5) (data not shown). The respiratory field samples (lung tissue samples) 
were also tested on the diagnostic 48.48DA for PCMV, PCV2, S. suis type 2, B. bronchiseptica and 
PCV3, which are not a part of the standard routine diagnostic testing scheme at the National 
Veterinary Institute (Table 6). The results revealed that PCMV and S. suis type 2 were highly 
prevalent. PCMV was detected with both low and high Cq values while S. suis type 2 was detected 
with mostly high Cq values. The remaining tested pathogens were sporadically detected with both 
low and high Cq values. However, since these samples were not tested using the Rotor-Gene Q 
platform no conclusion could be made in regards to sensitivity and specificity of these assays.       
 
Discussion 
To our knowledge, this is the first paper describing the use of the high-throughput qPCR BioMark 
platform as a diagnostic tool for detection of viral and bacterial pathogens in production animals. 
The high-throughput qPCR protocol for detection of respiratory and enteric viral and bacterial 
pathogens proved to be as specific and sensitive detection method as traditional qPCR. This new 
approach enables the combination of multiple assays and multiple samples run simultaneously in 
nanoliter volumes. This method requires less labour and reagent volumes compared to traditional 
qPCR methods, which require microliter volumes thus increasing the cost of analysis due to the use 
of higher amounts of expensive reagents. Furthermore, more working hours for set up and data 
analysis of the analyses are required. Recently, we designed a 48.48DA containing qPCR assays, 
which can differentiate between the different swIAV subtypes, circulating in European pigs 
(Goecke et al., 2018). The BioMark system has also been used as a screening and detection tool for 
food- and waterborne pathogens and for tick-borne diseases (Ishii et al., 2013; Michelet et al., 
2014). These studies found the system to offer sensitive as well as specific detection of 
miscellaneous pathogens. The BioMark system is a flexible tool, allowing easy modification of the 
assay panel by adding or removing assays, provided that the assays have been optimized to the PCR 
conditions chosen for the given setup (Ishii et al., 2013; Michelet et al., 2014). This is a great 
advantage for a screening and detection tool, since it eases preparedness to new pathogens or new 
variants emerge.  
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     The aim of the present study was to develop a diagnostic tool, which was specific for selected 
respiratory and enteric viral and bacterial pathogens of high importance to the swine industry in 
Denmark. The validation of the diagnostic 48.48DA with positive controls showed that pre-
amplification of the samples was needed due to the very small reaction volumes (Korenková et al., 
2015). The need for pre-amplification is in accordance with recommendations from the supplier and 
other studies using the BioMark for detection of pathogens (Ishii et al., 2013; Michelet et al., 2014; 
Spurgeon et al., 2008). In the present study, the pre-amplification of the target RNA and DNA was 
performed in two different setups. The pre-amplification of the DNA targets was performed 
according to supplier recommendations, while for the RNA targets, the cDNA synthesis and pre-
amplification setup was optimised to a one-step procedure instead of the two-step procedure, as 
described previously (Goecke et al., 2018).  
      The performance of the qPCR assays specific for the selected pathogens was initially evaluated 
on positive controls using both the high-throughput and traditional qPCR platforms. All the qPCR 
assays had an acceptable PCR efficiency between 85-110% on the two qPCR platforms and 
comparison of the assay performances revealed only a minor difference in the dynamic range and 
efficiency for all the assays. The dynamic range was either the same or had one log10 difference 
between the two platforms, while the assay specific for A. pleuropneumoniae was an exception. 
Here the two first samples (10
0
 and 10
-1
) were excluded from the dilution series analysed by the 
BioMark platform due to too low Cq values. As observed for A. pleuropneumoniae, very positive 
samples can result in false negative results in the BioMark analysis which can be due to an 
inhibition of the system. In cases where a sample has a very low Cq value a light yellow colour will 
appear in the heat map indicating a positive sample, however, the amplification curve might not 
have the right shape, which can question the result. In such cases, a dilution of the sample will be 
necessary.   
     To evaluate the performance of the diagnostic 48.48DA, field samples which have previously 
been tested in the routine veterinary diagnostic laboratory by qPCRs were tested on the diagnostic 
48.48DA. In general, there was a high degree of agreement for the results provided by the 
diagnostic laboratory and the results generated by the diagnostic 48.48DA. For a few of the tested 
faecal sock samples, there was a discrepancy between the two platforms, but the Cq value for the 
affected samples was relative high and therefore represent border line samples. However, a 
significant correlation between the two qPCR platforms was found for the four assays. The results 
obtained with the diagnostic 48.48DA for the oral fluid, lung tissue and liver tissue samples were 
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also consistent with the findings from the Rotor-Gene Q analyses with few exceptions. The assay 
specific for P. multocida was the assay, showing most discrepancies, but again these samples, 
except for one, were only weakly positive.  
     The use of the diagnostic 48.48DA for identification of respiratory and enteric viral and bacterial 
porcine pathogens provides new possibilities for veterinary diagnostics. The advantage of offering 
diagnostics for all relevant pathogens causing respiratory and intestinal diseases diminish the risk of 
not detecting the relevant pathogens in each specific case. The majority of the included pathogens 
were chosen based on their high prevalence in Danish pigs. However, additionally the diagnostic 
48.48DA also includes test for the newly described virus PCV3, which was firstly discovered in 
2016 in USA (Phan et al., 2016) and it has subsequently also been detected in Asia and Europe 
including Denmark (Franzo et al., 2018; Ku et al., 2017; Stadejek et al., 2017b).  
 
In conclusion, we have developed a sensitive and specific diagnostic approach for simultaneous 
detection of multiple respiratory and enteric viral and bacterial porcine pathogens by using a 
microfluidic high-throughput qPCR platform. This new screening and detection approach is a 
powerful tool with the capacity of analysing a large number of samples in a large number of qPCR 
assays in the same analysis. Furthermore, it is easy to modify the assay panel by adding or 
removing assays. Thereby, this tool can easily be adapted to new situations in which e.g. new 
pathogens or new variants emerge. With this diagnostic tool it is possible to offer diagnostic 
services with reduced costs and turnover time, which may facilitate the correct choice of disease 
control strategies such as vaccines and promote a reduction in medicine use. Internal calculations 
reveal that full implementation and automatization of the procedure can result in an analysis cost 
per sample less than 5% of the cost of traditional qPCR, and thereby the assay have great potentials 
for future disease surveillance of pathogens in production herds.  
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Table 1 Primer and probe sequences for virus detection. Modifications of published sequences are in bold 
Pathogen - Virus Target gene Name Sequence (5’-3’) Length (bp) Reference 
Rotavirus A 
 
NSP3 Rota A-F 
Rota A-R 
Rota A-P 
ACCATCTACACATGACCCTC 
GGTCACATAACGCCCC 
FAM-ATGAGCACAATAGTTAAAAGCTAACACTGTCAA-TAMRA 
87  
 
(Pang et al., 
2004) 
Swine influenza A 
virus  
 
 
M 
 
 
 
H1 (A(H1N1)pdm09) 
M-F 
M-R 
M-P 
 
H1pdm-F 
H1pdm-R 
H1pdm-P 
AGATGAGTCTTCTAACCGAGGTCG 
TGCAAAGACACTTTCCAGTCTCTG 
FAM-TCAGGCCCCCTCAAAGCCGA-BHQ1 
 
AATGCCGAACTGTTGGTTCT 
CAATTTCCTTGGCATTGTTTT 
FAM-CTGGCTTCTTACCTTTT*(BHQ1)CATATAAGTTCTTC 
101 
 
 
 
118 
 
F and P modified 
from (Loeffen et 
al., 2011) 
R: this study 
(Slomka et al., 
2010) 
Porcine circovirus 
type 2  
 
 
CAP PCV2-F 
PCV2-R 
PCV2-P 
 
GATGATCTACTGAGACTGTGTGA 
AGAGCTTCTACAGCTGGGACA 
FAM-TCAGACCCCGTTGGAATGGTACTCCTC-BHQ1 
 
152  
 
Modified from 
(Ladekjær-
Mikkelsen et al., 
2002) 
Porcine circovirus 
type 3  
CAP PCV3-F 
PCV3-R 
PCV3-P 
AGTGCTCCCCATTGAACG 
ACACAGCCGTTACTTCAC 
FAM-ACCCCATGGCTCAACACATATGACC-BHQ1 
135 Modified from 
(Palinski et al., 
2017) 
Porcine parvovirus  
 
 
NS1 
 
PPV-F 
PPV-R 
PPV-P 
ACCGCCAGATTCAGCARTAC 
ACCTTATTCAAGGTTTGTTGTGGG 
FAM-CACCAAAGCAGGCTCTTATGTCGGTTTCTA-BHQ1 
113  
 
F and P from Dia1 
R: this study 
Porcine reproductive 
and respiratory 
syndrome virus type 
1 (EU) 
 
ORF7 
 
 
 
ORF6 
 
 
 
ORF5 
 
 
PRklm EU1-F 
PRklm EU1-R 
PRklm EU1-P 
 
PRklm EU2-F 
PRklm EU2-R 
PRklm EU2-P 
 
Nadir-F 
Nadir-R 
Nadir-P 
GCACCACCTCACCCRRAC 
CAGTTCCTGCRCCYTGAT 
FAM-CCTCTGYYTGCAATCGATCCAGAC-BHQ1 
 
CAGATGCAGAYTGTGTTGCCT 
TGGAGDCCTGCAGCACTTTC 
FAM-ATACATTCTGGCCCCTGCCCAYCACGT-BHQ1 
 
TTYGGGTTCACHGTCGCAG 
GACCTTCGATARTTCGGGAG 
FAM-CAGAGCGCGAACGGAGAAKCGCG-BHQ1 
77 
 
 
 
78 
 
 
 
108 
(Wernike et al., 
2012) 
 
 
(Wernike et al., 
2012) 
 
 
(Stadejek et al., 
2017a) 
Porcine reproductive 
and respiratory 
syndrome virus type 
2 (US) 
ORF7 PRklm NA-F 
PRklm NA-R 
PRklm NA-P
  
ATRATGRGCTGGCATTC 
ACACGGTCGCCCTAATTG 
FAM-TGTGGTGAATGGCACTGATTGACA-BHQ1 
114 Modified from 
(Kleiboeker et al., 
2005) 
Porcine 
Cytomegalovirus  
 
DPOL Pol-F 
Pol-R 
Pol-P 
CTGCCGTGTCTCCCTCTAG 
ATTGTTGATAAAGTCACTCGTCTGC 
FAM-CCATCACCAGCATAGGGCGGGAC-BHQ1 
81  
 
Modified from 
(Fryer et al., 
2004) 
1 Dia = The diagnostic veterinary laboratory at the National Veterinary Institute, Technical University of Denmark   
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Table 2 Primer and probe sequences for bacteria detection. Modifications of published sequences are in bold 
Pathogen - Bacteria Target gene Name Sequence (5’-3’)  Length (bp) Reference 
B. pilosicoli 23S rRNA 
 
B.pilo-F  
B.pilo-R  
B.pilo-P 
GTAGTCGATGGGAAACAGGT 
TTACTCACCACAAGTCTCGG 
FAM-TATTCGACGAGGATAACCATCACCT-BHQ1 
124 (Ståhl et al., 2011) 
L. intracellularis 16S rRNA Law-F 
Law-R 
Law-P 
GCGCGCGTAGGTGGTTATAT 
GCCACCCTCTCCGATACTCA 
FAM-CACCGCTTAACGGTGGAACAGCCTT-TAMRA 
98 (Lindecrona et al., 2002) 
E. coli type F4 faeG
  
 
E.coli F4-F 
E.coli F4-R 
E.coli F4-P  
CACTGGCAATTGCTGCATCT 
ACCACCGATATCGACCGAAC 
FAM-TCACCAGTCATCCAGGCATGTGCC-TAMRA 
86 (Frydendahl et al., 2001) 
E. coli type F18 fedA E.coli F18-F 
E.coli F18-R  
E.coli F18-P  
GGCGGTTGTGCTTCCTTGT 
CCGTTCACGGTTTTCAGAGC 
FAM-TAACTGCCCGCTCCAAGTTATATC AGCTGTT-TAMRA 
128 (Frydendahl et al., 2001) 
M. hyopneumoniae 
 
 
 Mhp-F 
Mhp-R 
Mhp-P 
GGCAATTCCAAGAGTTATTCAGG 
TTCCGACAAGTTTTTCACCATTAG 
FAM-TGATGGACTAATTGATAAAGTTCTAAACCATCG-BHQ1 
147 
 
This study 
A. pleuropneumoniae  omlA 
 
AP-F 
AP-R 
AP-P 
AGTGCTTACCGCATGTAGTGGC 
TTGGTGCGGACATATCAACCTTA 
FAM-CGATGAACCCGATGAGCCGCC-TAMRA 
92 
 
(Angen et al., 2001) 
 
P. multocida 
 
 
kmt1 
 
PM-F  
PM-R  
PM-P 
GACTACCGACAAGCCCAC 
ATCCGCTATTTACCCAGTGG 
FAM-GTGCGAATGAACCGATTGCCGCG-BHQ1 
123 
 
R from (Townsend et al., 
1998) 
F and P: this study 
S. suis type 2 
  
 
gdh SS-F 
SS-R 
SS-P 
CCAAAGCTTCATGACTGAATTGC 
CGACCACCGACACCGATG 
FAM-ACACATCGGACCTTCACTTGACGTC-BHQ1 
81  
 
Modified from (Yang et al., 
2010) 
B. bronchiseptica 
 
 
dnt BB-F 
BB-R  
BB-P 
 
GGCGGTACTTGGGATAATAGA 
GAAGAGTCCGGGGATCTTG 
FAM-CGAGCATCCTGGCCGATGGGTTC-BHQ1 
 
136  
 
F modified from 
(Stepniewska et al., 2010) 
R and P: This study 
M. hyorhinis 
 
 
p37 
 
 
Mhr-F 
Mhr-R  
Mhr-P 
CAAGCTTCYGAAACACCAAATG 
CGCCAATAGCATTTGCTATATC 
FAM-CAGGAGTAGTCAAGCAAGAGGATG-BHQ1 
115  
 
This study 
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Table 3 Relative sensitivity of qPCR assays on the Rotor-Gene Q platform and on the diagnostic 48.48DA (BioMark platform) 
 Assays 
Bacteria 
dilution 
B. pilosicoli L. intracellularis E. coli F4 E. coli F18 P. multocida 
Rotor-Gene BioMark Rotor-Gene BioMark Rotor-Gene BioMark Rotor-Gene BioMark Rotor-Gene BioMark 
10 15.53 6.96 14.84 5.88 17.03 8.26 19.84 11.01 11.1 4.40 
10-1 18.80 10.41 18.03 8.99 20.26 10.90 23.07 14.74 15.63 6.90 
10-2 22.19 13.68 21.31 12.40 23.56 14.54 26.61 18.29 18.39 9.32 
10-3 25.78 16.66 24.65 16.30 27.07 17.99 30.05 22.29 22.35 13.21 
10-4 28.99 20.13 28.30 19.66 30.03 21.43 33.17 25.52 24.82 16.54 
10-5 32.50 24.75 31.68 23.23 33.78 24.57 35.91 neg 27.93 20.07 
10-6 neg neg neg 25.54 neg neg neg neg 31.76 neg 
10-7 neg neg neg neg neg neg neg neg neg neg 
Effectivity  0.97 0.95 0.98 0.96 1.00 1.00 1.03 0.89 1.00 1.06 
 
 
 Assays 
Bacteria 
dilution 
B. bronchiseptica S. Suis type 2 A. pleuropneumoniae M. hyorhinis M. hyopneumoniae 
Rotor-Gene BioMark Rotor-Gene BioMark Rotor-Gene BioMark Rotor-Gene BioMark Rotor-Gene BioMark 
10 - - - - 8.72 (3.68)* 13.27 5.99 22.52 12.10 
10-1 16.06 5.71 12.89 5.06 11.44 (3.83)* 16.31 8.63 25.30 15.40 
10-2 19.56 7.46 16.11 7.75 14.70 5.98 19.52 11.67 29.26 19.68 
10-3 22.94 10.91 19.85 10.82 18.00 9.14 22.75 15.88 32.86 22.98 
10-4 26.73 14.44 22.90 14.39 21.64 12.40 25.99 19.02 36.17 neg 
10-5 30.02 17.75 26.40 16.99 25.30 16.17 29.60 21.74 neg neg 
10-6 33.56 20.72 29.93 20.47 28.49 19.26 33.10 24.73 neg neg 
10-7 neg 25.18 32.99 24.66 32.06 22.38 neg neg neg neg 
10-8 neg neg neg (25.90)* 34.29 neg neg neg neg neg 
10-9 neg neg neg neg neg neg neg neg neg neg 
Effectivity  0.93 1.06 0.97 1.06 1.00 1.01 1.01 1.01 0.94 0.85 
* Number in parenthesis is not included in the effectivity calculation  
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Table 3 continued Relative sensitivity of qPCR assays on the Rotor-Gene Q platform and on the diagnostic 48.48DA (BioMark platform) 
Assays 
Viral 
dilution 
swIAV (M) swIAV (H1pdm) Rotavirus A PCV2 PCV3 PPV 
Rotor-Gene BioMark Rotor-Gene BioMark Rotor-Gene BioMark Rotor-Gene BioMark Rotor-Gene BioMark Rotor-Gene BioMark 
10 - - - - 22.19 14.50 14.01 5.18 17.33 7.27 18.7 9.61 
10-1 13.69 3.68 16.42 14.02 25.55 18.05 17.24 7.76 20.51 9.60 22.12 13.32 
10-2 17.25 5.18 19.95 17.41 28.73 20.64 20.59 11.09 24.50 13.32 25.92 17.21 
10-3 20.69 8.62 23.51 20.21 32.13 24.65 23.94 14.67 27.41 16.30 29.27 20.84 
10-4 24.15 12.67 27.13 24.03 (34.86)* neg 27.48 17.60 30.98 19.83 33.51 24.17 
10-5 26.91 16.17 30.25 27.61 neg neg 31.22 20.73 34.35 22.51 36.46 neg 
10-6 29.32 19.71 33.48 neg neg neg 34.03 24.40 36.60 26.32 neg neg 
10-7 neg 23.51 neg neg neg neg neg neg neg neg neg neg 
10-8 neg neg neg neg neg neg neg neg neg neg neg neg 
Effectivity  1.07 0.96 0.96 0.96 1.01 1.03 0.97 1.04 1.00 1.05 0.89 0.87 
* Number in parenthesis is not included in the effectivity calculation   
 
Assays 
Viral 
dilution 
PRRSV type 1 (EU1) PRRSV type 1 (EU2) PRRSV type 1 (Nadir) PRRSV type 2 (NA) PCMV 
Rotor-Gene BioMark Rotor-Gene BioMark Rotor-Gene BioMark Rotor-Gene BioMark Rotor-Gene BioMark 
10 19.17 13.54 - 10.17 14.69 10.86 - 16.48 12.15 3.50 
10-1 22.01 17.27 20.74 14.33 18.29 14.35 21.51 20.59 15.76 6.12 
10-2 25.41 19.91 23.57 17.49 21.58 17.38 24.44 24.47 18.71 9.43 
10-3 28.53 22.51 27.51 20.20 25.19 20.71 28.14 27.60 21.93 12.84 
10-4 32.09 26.31 30.79 23.63 28.75 25.35 31.79 31.19 25.66 15.80 
10-5 35.72 28.02 33.76 28.50 32.18 neg 34.08 neg 29.22 19.33 
10-6 neg neg 37.29 neg neg neg neg neg 31.8 22.60 
10-7 neg neg neg neg neg neg neg neg 33.97 neg 
10-8 neg neg neg neg neg neg neg neg neg neg 
Effectivity  0.99 1.10 1.00 0.93 0.93 0.96 1.03 1.00 1.06 1.02 
7
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Table 4 Faecal sock samples analysed on the Rotor-Gene Q and BioMark platforms. - = no Cq, PCC = Pearson correlation 
coefficient. Differences are marked in red 
Sample B. pilosicoli L. intracellularis E. coli F4 E. coli F18 
 Rotor-Gene BioMark Rotor-Gene BioMark Rotor-Gene BioMark Rotor-Gene BioMark 
17-18303-1 - - 26.47 19.81 - - - - 
17-18304-1 - - - - 29.24 21.33 26.90 23.44 
17-18305-1 - - - - - - 26.07 21.62 
17-18306-1 25.68 23.41 26.19 18.31 - - - - 
17-18307-1 - - - - 30.29 22.29 25.58 22.79 
17-18308-1 29.13 31.17 25.02 15.28 - - - - 
17-18309-1 - - - - - - 25.51 19.36 
17-18310-1 - - 28.73 20.69 - - - - 
17-18311-1 - - 29.7 21.66 30.48 23.77 24.90 19.60 
17-18312-1 - - - 26.56 - - 30.88 28.68 
17-18313-1 - - - - - - 23.49 18.48 
17-18315-1 - - 22.83 14.23 29.79 22.03 26.66 23.10 
17-18316-1 28.6 - 24.99 17.93 28.53 22.09 25.86 30.95 
17-18317-1 - - 20.74 11.93 - - - - 
17-18318-1 24.76 21.53 - - - - - - 
17-18319-1 27.90 29.46 29.28 20.88 33.05 25.48 29.17 25.55 
17-18320-1 25.72 19.24 25.94 17.67 - - 37.29 34.11 
17-18321-1 25.63 - 25.46 18.45 - - 36.74 - 
17-19768-1 - - 30.71 21.51 - - 28.76 25.53 
17-19769-1 - - 28.98 21.48 - - - - 
17-19770-1 - - - - 28.84 21.05 - - 
17-19771-1 - - 25.00 15.41 - - 27.01 22.80 
17-19772-1 22.99 16.39 23.94 14.67 - - 21.20 14.71 
17-19773-1 24.06 18.94 24.55 15.47 - - 32.13 29.75 
17-19774-1 23.98 17.66 22.94 14.17 - - - - 
17-19775-1 24.76 18.04 20.06 11.45 - - - - 
17-19776-1 26.59 21.57 24.27 15.34 - - - - 
17-19777-1 30.15 25.08 19.88 10.81 - - - - 
17-19778-1 25.77 22.17 29.86 20.26 - - 30.19 26.19 
17-19779-1 32.07 26.94 35.34 25.55 - - 30.07 24.67 
17-19780-1 28.25 22.58 20.86 11.66 - - - - 
17-19781-1 30.96 24.43 29.02 19.76 - - - - 
17-19782-1 25.90 21.17 22.53 13.47 - - - - 
17-19783-1 30.86 26.06 22.89 13.41 - - - - 
17-19783-2 24.54 19.11 33.32 23.66 - - 30.99 24.69 
17-19783-3 29.38 32.91 - - - - - - 
In total 21/36 19/36 27/36 28/36 7/36 7/36 19/36 18/36 
PCC 0.771 0.976 0.918 0.845 
p-value 0.0001 0.00001 0.004 0.00001 
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Table 5 Lung tissue samples analysed on the Rotor-Gene Q and BioMark platforms. mas = massive (Cq value < 25), mod = moderate (Cq value 25-30),  
low (Cq value 30-33), - = negative, grey = no analysis. Differences are marked in red 
  A. pleuropneumoniae M. hyorhinis M. hyopneumoniae P. multocida PRRSV type 2 
Sample Material Rotor-Gene BioMark Rotor-Gene BioMark Rotor-Gene BioMark Rotor-Gene BioMark Rotor-Gene BioMark 
89-1 Lung - - - - + 19.01 mas 10.90   
89-2 Lung - - - - + 23.85 mas 5.89   
89-3 Lung - - - - + 16.80 mas 15.82   
443-1 Lung - - mas 8.65 - - mas 15.06   
710-1 Lung - - mas 11.65 - - - -   
710-2 Lung - - low 25.79 - - - -   
710-3 Lung - - mas 9.60 - - - -   
1275-1 Lung mas 10.26 - - - - low 24.16   
1275-2 Lung mod 19.01 - - - - - -   
1908-1 Lung mod 18.72 mas 7.65 - - mas 12.56   
1908-2 Lung mas 6.31 mas 13.81 - - mas 10.45   
1908-3 Lung mas 15.18 mas 15.15 - - mas 20.81   
1991-1 Lung - - mas 10.25 - - mas 11.06   
1991-2 Lung - - mas 7.96 - - mod 21.80   
1991-3 Lung - - mas 11.84 - - mas -   
2511-1 Lung mas 14.87 mas 16.45 - - low -   
2512-1 Lung mod 17.85 - - - - - -   
2512-2 Lung mas 12.01 - - - - - -   
2512-3 Lung mas 4.64 - - - - - -   
2919-1 Lung mas 16.38 low - - - - -   
2919-2 Lung low 21.75 mas 16.22 - - - -   
2985-1 Lung - - - - + 17.93 mas 15.25   
2985-2 Lung - - - - + 14.29 mas 13.71   
2985-3 Lung - - - - + 19.83 mas 11.33   
3148-1 Lung - - - - + 19.61 mod 19.94   
3148-2 Lung - - - - + 14.01 - 30.46   
3148-3 Lung - - - - + 21.36 - 24.97   
3368-1 Lung low 22.37 low 25.89 + 12.83 low -   
3368-2 Lung mas 16.75 - - + 18.56 mod 18.27   
3368-3 Lung mas 9.30 - 27.56 + 18.03 mas 12.44   
455-5 Lung         26.2 26.07 
455-6 Lung         31.2 - 
3386-1 Lung  -  - + 16.61 mas 16.57   
3953-2 Lung  -  19.34 - - low -   
3953-3 Lung  -  16.79 - - mas 11.90   
4506-1 Lung  24.19  - + 13.32 - 26.62   
4506-2 Lung  20.70  - - - mas 18.46   
4506-3 Lung  4.69  17.81 + 16.02 mas 10.18   
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Table 6 Lung tissue samples analysed on the BioMark platform. - = negative, grey = no analysis 
  Diagnostic 48.48 DA (BioMark platform) 
Sample Material PCMV PCV2 S. Suis type 2 B. bronchiseptica PCV3 
89-1 Lung - 18.52 25.83 - 19.34 
89-2 Lung 22.14 - 20.22 - 18.95 
89-3 Lung - - - - - 
443-1 Lung 11.52 - 21.01 12.05 - 
710-1 Lung 17.01 - - - - 
710-2 Lung 10.33 - 27.76 - - 
710-3 Lung 9.44 - 24.09 - - 
1275-1 Lung 21.74 - 27.83 - 14.78 
1275-2 Lung - 27.33 - - 21.06 
1908-1 Lung 17.22 21.69 21.85 - - 
1908-2 Lung 12.16 22.46 20.21 - - 
1908-3 Lung 18.08 26.52 26.70 - - 
1991-1 Lung 11.21 - 18.85 - - 
1991-2 Lung 12.99 - 27.15 - - 
1991-3 Lung 13.67 - 21.06 - - 
2511-1 Lung 21.55 6.69 - - - 
2512-1 Lung 19.16 - - 27.00 - 
2512-2 Lung 7.91 - 23.78 21.33 - 
2512-3 Lung 18.30 - 27.24 26.04 - 
2919-1 Lung 13.66 - - - - 
2919-2 Lung 15.38 - 19.08 - - 
2985-1 Lung - - - - - 
2985-2 Lung 24.31 - 25.93 - 29.55 
2985-3 Lung - - - - - 
3148-1 Lung 23.21 - 27.77 - - 
3148-2 Lung 23.90 - - - - 
3148-3 Lung 22.44 13.03 26.77 - 17.75 
3368-1 Lung 14.36 - 21.83 - 17.93 
3368-2 Lung 18.00 - 24.18 - - 
3368-3 Lung 16.13 - 19.23 - - 
455-5 Lung      
455-6 Lung      
3386-1 Lung 26.77 21.17 - - 19.92 
3953-2 Lung 8.18 - 25.10 15.63 - 
3953-3 Lung 11.21 - 24.34 15.76 - 
4506-1 Lung 18.55 - 15.82 - - 
4506-2 Lung 14.10 - 21.06 26.73 - 
4506-3 Lung 23.38 - 14.90 23.40 15.73 
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Figure 1 Heat map showing the specificity of the qPCR assays included on the diagnostic 48.48DA by testing known 
positive samples (controls). At the top: The qPCR assays (Table 1 and 2). To the left: The positive samples (controls), a 
Non-Template Control (NTC), a negative cDNA/pre-amplification control and a negative pre-amplification control.  
Each square corresponds to a single real-time PCR reaction. Cq values for each reaction are indicated by colour; the 
corresponding colour scale is presented in the legend on the right. A black square is considered as a negative result. The 
black cross is shown if the amplification curve deviates too much from an ideal amplification curve.   
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Abstract 
Infectious diseases are of great economic importance in pig production, causing both clinical and 
subclinical disease, and influences welfare, productivity, and antibiotic use. The causes of these 
diseases are often multifactorial and laboratory diagnostics are not routinely performed. The aim of 
the current study was to explore the benefits of monthly health monitoring in nursery and finisher 
herds and to examine correlations between laboratory results and observed clinical signs, including 
coughing and diarrhoea. Three monthly samplings were conducted in three different age groups in 
six nursery and four finisher herds. For each herds, two pens were randomly selected in each age 
group and evaluated for coughing and diarrhoea events. Furthermore, faecal sock and oral fluid 
samples were collected in the selected pens and analysed for 17 respiratory and enteric viral and 
bacterial pathogens using the high-throughput real-time PCR BioMark platform (Fluidigm). A total 
of 174 pens were sampled in which eight coughing events and 77 diarrhoeic events were observed. 
The overall findings showed that swine influenza A virus, porcine circovirus 2, porcine 
cytomegalovirus, Brachyspira pilosicoli, Lawsonia intracellularis, Escherichia coli fimbria type F4 
and F18 were found to be prevalent in several of the herds. Significant correlations between 
coughing events and the presence of swine influenza A virus, porcine cytomegalovirus (Cq ≤ 20) or 
a combination of these were found. Furthermore, a significant correlation between diarrhoeic events 
and the presence of L. intracellularis (Cq ≤ 24) or B. pilosicoli (Cq ≤ 26) was found. The use of 
high-throughput real-time PCR analysis for continuous monitoring of pathogens and thereby 
dynamics of disease in a pig herd, provided the veterinarian and farmer with an objective 
knowledge on the distribution of pathogens in the herd. In addition, the use of a high-throughput 
method in combination with information about clinical signs, productivity, health status and 
antibiotic consumption, presents a new and innovative way of diagnosing and monitoring pig herds 
and even to a lower cost than the traditional method.    
 
Keywords 
Diagnostics, monitoring, high-throughput real-time PCR, coughing index, diarrhoea index, 
respiratory viruses, respiratory bacteria, enteric viruses, enteric bacteria. 
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Introduction 
Infectious diseases such as respiratory and intestinal diseases are of major importance in pig 
production due to clinical and subclinical diseases, which can result in reduced productivity, 
impaired animal welfare, increased mortality and increased consumption of antibiotics. The cause 
of these diseases are often multifactorial and the prevalence and combination of pathogens can 
fluctuate over time due to e.g. changes in management, environment, season or stage of production 
(Hansen et al., 2010; Heo et al., 2013; Hernandez-Garcia et al., 2017; Opriessnig et al., 2011; Stärk, 
2000).  
     Respiratory diseases are one of the major problems in modern pig production worldwide and are 
often referred to as Porcine Respiratory Disease Complex (PRDC), which is a polymicrobial 
infection caused by a combination of various primary and secondary respiratory viral and bacterial 
pathogens. Environmental conditions, management factors, population size and factors such as age 
and genetic also play roles in the outcome of PRDC (Opriessnig et al., 2011; Thacker, 2001). 
Agents associated with PRDC are e.g. porcine circovirus type 2 (PCV2), porcine cytomegalovirus 
(PCMV), porcine reproductive and respiratory syndrome virus (PRRSV), swine influenza A virus 
(swIAV), Actinobacillus pleuropneumoniae, Bordetella bronchiseptica, Haemophilus parasuis, 
Mycoplasma hyopneumoniae, Mycoplasma hyorhinis, Pasteurella multocida and Streptococcus 
suis. PRDC is most commonly observed in growing and finishing pigs, with mortality rates ranging 
from 2-10% and morbidity rates ranging from 10-40%. The clinical picture of the complex is 
characterized by coughing, fever, dyspnoea, decreased feed intake and even fatal pneumonia 
(Brockmeier et al., 2002; Harms et al., 2002; Kim et al., 2003; Opriessnig et al., 2011; Thacker, 
2001). 
     Pathogens involved in respiratory disease in pigs vary among countries, herds and production 
sites, making general treatment and control regimes for PRDC difficult to develop (Gutiérrez-
Martín et al., 2000; Harms et al., 2002). Due to the polymicrobial nature of the disease, a range of 
different diagnostic samples and techniques may be employed in the investigation of a single case, 
including nucleic acid, antigen and antibody detection. For this, oral fluid samples are ideal for 
diagnosing PRDC due to the residency of the pathogens in the respiratory tract (Hernandez-Garcia 
et al., 2017). The use of oral fluid as a sampling method is a relatively new diagnostic method used 
for detection of pathogens. This sampling method has the advantage that it is practical, minimizes 
stress on the animals, offers the possibility of testing a large number of individuals in an aggregate 
sample and is economically beneficial compared to blood sample collection (Gibert et al., 2017; 
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Hernandez-Garcia et al., 2017; Prickett and Zimmerman, 2010). On the other hand, analysing oral 
fluid samples can be challenging due to the risk of contamination from faeces, nasal secretions or 
from the environment. Furthermore, isolating RNA from these biological samples can be difficult as 
it is easily degraded. Therefore, pre-processing and storage conditions such as time and temperature 
can be critical in the analysis of oral fluid samples (Gibert et al., 2017; Hernandez-Garcia et al., 
2017).  
     Intestinal diseases are another critical factor in modern pig production. The multifactorial 
disease “post-weaning diarrhoea” is associated with dehydration, reduced feed intake and thereby 
reduced growth and increased mortality (Heo et al., 2013). Intestinal diseases in pigs can be caused 
by a wide range of viral and bacterial pathogens. The most frequently detected pathogens associated 
with intestinal disease in nursery pigs are Lawsonia intracellularis, Brachyspira pilosicoli, 
Escherichia coli fimbria type F4 and F18, whereas for finisher pigs especially L. intracellularis and 
B. pilosicoli are involved in enteric disease (Jacobson et al., 2003; Pedersen et al., 2014). The 
viruses; rotavirus A and PCV2 can also cause enteric disease. Rotavirus A is a known diarrhoea 
causing agent in pigs and has been associated with acute gastroenteritis, usually seen in young 
animals (Bohl et al., 1978; Saif and Fernandez, 1996). PCV2 has not been proven to be the primary 
cause of diarrhoea in pigs, however, systemic PCV2 may indirectly contribute to enteric diseases 
due to its immunosuppressive effect (Jensen et al., 2006; Johansen et al., 2013; Segalés, 2012). 
Coronaviruses such as transmissible gastroenteritis virus, porcine deltacoronavirus and porcine 
epidemic diarrhoea virus can also induce enteric diseases, but Denmark and many other European 
countries are free of these viruses (Pensaert and Martelli, 2016). 
     The use of laboratory diagnostics in Danish pig production is limited and is often carried out 
only once a year, which is a requirement before batch medication can be used according to Danish 
legislation. The results of the diagnostic tests of these random cross-sectional samples are often of 
limited value and therefore, prophylactic and therapeutic interventions are often initiated based 
solely on clinical signs. The major reason for the limited use of laboratory diagnostics is that the 
traditional methods are expensive and resource demanding. To overcome these limitations, we have 
developed a high-throughput real-time PCR (qPCR) detection system using the BioMark platform 
(Fluidigm, South San Francisco, USA) (Goecke et al., 2018), which is capable of detecting 
significant porcine viruses and bacteria in the same setup.  
     The aim of the present study was to test if ongoing monthly diagnostic monitoring of pathogens 
on herd level could be used as a supportive tool in veterinary consultancy, combined with clinical 
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observations and production data, to create a more objective basis for intervention. Furthermore, the 
study aimed to investigate the prevalence of the different pathogens and their relation to clinical 
disease with a special focus on pathogens involved in PRDC and enteric diseases in pigs after 
weaning.  
 
Materials and methods 
Study design and herd inclusion criteria  
The study was carried out as a repeated cross-sectional study in ten pig herds located on Zealand, 
Denmark. The target populations of each herd consisted of three different age groups in the nursery 
and finisher pigs. For each herd, sampling and clinical registrations were conducted monthly over a 
three months period from September to November 2017. Six nursery (1N, 2N, 3N, 4N, 5N and 6N) 
and four finisher (1F, 2F, 3F and 6F) herds were included in the study, of which herds 2, 3, 4, 5 and 
6 were specific pathogen free (SPF) herds and herd 1 was a conventional herd. All herds were free 
of PRRSV at the beginning of the study. General information on the herds and their vaccination 
strategies was obtained from questionnaires filed out by the herd owners (Table 1).  
 
Sampling strategy and clinical observation  
At each sampling, three different age groups in each herd were sampled (Figure 1). In the nursery 
herds, pigs were sampled approximately two, five, and seven weeks after weaning. In the finisher 
herds, pigs were sampled approximately two, six, and ten weeks after arrival. Samplings were 
always conducted at the same location/herd if a farm consisted of multiple finisher herds, 
occasionally resulting in a deviation from the sampling age with two weeks. To reduce the spread of 
disease, the youngest pigs were always sampled first. Two pens from each age group were 
randomly included in the study, representing this age group. By lottery, one pen was first chosen. 
To minimize environmental factors and to maximize the distance between the study pens, the other 
pen was chosen by turning to the pen just opposite of the aisle and then move a defined number of 
pens downwards, calculated by dividing the number of pens in a row by two (Figure 1). In herd 5N, 
four nursery pens were included per age group due to the small numbers of pigs housed per pen. 
Hospital pens were excluded from the study. Due to the cross-sectional study design, the same pens 
were not target to be sampled at the next sampling month, although this could happen by 
coincidence.  
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     At each sampling, the coughing index, which is a method to quantify coughing in groups of pigs, 
was calculated (Nathues et al., 2012). The pigs in the study pens were counted and forced to move 
if sleeping. Coughs were then counted for three minutes. If the same pig was coughing more than 
once within a ten second period, this coughing episode was noted, however, only counted once in 
the total number of coughs. Based on the coughing index, a coughing event was defined to 
determine if the pen was a coughing or a non-coughing pen. If the coughing index was ≥ 0.2, the 
pen was defined as having a coughing event (Tolstrup et al., 2017). Similarly, the incidence of 
diarrhoea was evaluated at each sampling by using a descriptive classification scale described by 
Pedersen and Toft, 2011 (Pedersen and Toft, 2011). Here, a diarrhoeic event was calculated and 
used to classify whether a pen had diarrhoea or not (Tolstrup et al., 2018). 
 
Sampling of oral fluid and faecal sock samples 
In total, 172 oral fluid samples were collected from nursery and finisher pigs through the 
application of an oral fluid sampling kit (Dianova, Kgs. Lyngby, Denmark). Oral fluid sampling 
was performed pen-wise by tying a cotton rope to the gate of the pen 20-30 cm above the floor 
(height adjusted to the size of the pigs). For approximately 30 min, the pigs were allowed to chew 
on the rope and thereby deposit oral fluid in the rope. After 30 min, the rope was collected and 
placed in a plastic bag, squeezed and oral fluid extracted in a 10 mL centrifuge tube. To minimize 
cross-contamination between samples, disposable gloves and new scalpels were used for each pen. 
     In addition, 174 faecal sock samples were collected from nursery and finisher pigs by means of a 
sock sampling kit (Dianova). One sock sampling kit was used per pen. Faecal sock samples were 
acquired by treading through the faecal contaminated part of the pen wearing the sampling socks as 
previously described (Pedersen et al., 2015). 
     Oral fluid and faecal sock samples were marked with specific identification numbers with 
information on pen, herd, age group, sample type, and date. All samples were stored in a 
polystyrene box containing freezer packs before delivery to the National Veterinary Institute, 
Technical University of Denmark. After delivery, all samples were kept under cooled conditions in 
a refrigerator at approximately 5 degrees for a maximum of 48 hours until preparation. Oral fluid 
samples were dispensed and stored at -80°C for RNA and DNA extraction. For each of the faecal 
sock samples, a 10% faeces dilution was prepared in phosphate buffered saline (PBS) and stored at 
-20°C for RNA and DNA extraction. 
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Nucleic acid extraction 
Oral fluid samples were extracted using the extraction robot QIAcube HT (QIAGEN, Hilden, 
Germany) and Cador pathogen 96 QIAcube HT kit (QIAGEN). The Cador pathogen 96 QIAcube 
HT protocol (QIAGEN) was applied with the following modifications; the input volume was 
increased from 200 to 400 μL and the volume of lysis buffer VXL was increased from 100 to 200 
μL. Before extraction, 1000 μL of each oral fluid sample was centrifuged for 5 min at 9000 x g at 
room temperature (15–25°C) and 400 µL of the supernatant was used for extraction together with 
positive and negative (nuclease-free water, Amresco) controls. The nucleic acid extractions were 
stored at -80°C until further analysis. 
    The 10% faeces dilution samples were extracted using the QIAsymphony SP system (QIAGEN) 
extraction robot and QIAsymphony DSP virus/pathogen mini kit (QIAGEN) following the 
manufacturer’s instructions. For this, the protocol Complex200_V5_DSP was used with an elution 
volume of 110 µL. Prior to the nucleic acid extraction, one 5 mm steel bead was added to each 
sample following which the samples were homogenized in a Tissuelyser II (QIAGEN) for 20 sec at 
15 Hz. The homogenate was then centrifuged for 90 sec at 10,000 rpm and 350 µL of the 
supernatant was used for nucleic acid extraction together with positive and negative (nuclease-free 
water, Amresco) controls. The nucleic acid extractions were stored at -80°C until further analysis.      
 
Pathogen detection by high-throughput real-time PCR  
Extracted oral fluid and faecal sock samples were both reverse transcribed/pre-amplified and pre-
amplified as previously described (Goecke et al., 2018). For high-throughput qPCR amplification, 
the BioMark 48.48 dynamic array (48.48DA) system (Fluidigm, South San Francisco, USA) was 
used, which combines 48 pre-amplified samples with 48 assays for 2,304 individual and 
simultaneous qPCR reactions. The qPCR assays and procedure used for the high-throughput qPCR 
analysis in the present study have previously been described and validated in the study by Goecke 
et al., 2018 (Goecke et al., 2018). qPCR assays were performed in duplicates and samples were 
performed in single reactions. Three positive controls, containing positive controls for the included 
assays, two non-template controls (nuclease-free water, Amresco), a non-template cDNA/pre-
amplification and a non-template pre-amplification control (nuclease-free water, Amresco) were 
included on each 48.48DA to control for non-specific amplification and sample contamination. 
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Statistical analysis 
The correlation between the presence of a pathogen and clinical signs in a pen was investigated 
using chi-square test or Fishers exact probability test, if cell frequencies were less than five. For the 
respiratory pathogens, the Fishers exact probability test (two-tailed) was used with the following 
parameters; presence vs. absence of pathogens and coughing event vs. no coughing event. For the 
intestinal pathogens, the chi-square test (with Yates correction) was used with the following 
parameters; presence vs. absence of pathogens and diarrhoeic event vs. no diarrhoeic event. For 
comparison of the mean quantification cycle (Cq) values between September, October and 
November 2017 the one-way analysis of variance (ANOVA) test and the t-test were used. The 
analyses were performed using Graph Pad Prism version 7.0. 
 
Results 
In total, 174 pens in ten herds were included in the study. In addition to the clinical registrations of 
coughing and diarrhoea, 172 oral fluid and 174 faecal sock samples were collected. The clinical 
registrations recorded eight coughing events (4.7% of the pens) during the three months of 
sampling, and the events were only observed in the nursery pigs. Furthermore, 77 of the collected 
pens were defined as pens with diarrhoeic events (44.3%) of which 53.2% of the nurseries and 
46.8% of the finishers were affected. Registrations of mortality and medical treatments on pen or 
batch level were not carried out consistently throughout all the investigated herds, and therefore, 
these data could not be included in the study. In all herds, the diagnostic results were consistent 
with the SPF status of the herds. PRRSV type 1 and 2 were not detected in any of the herds.  
     For swIAV, two different assays were included in the high-throughput qPCR analysis, one 
general swIAV assay detecting all known subtypes of swIAV and an assay specific for the human 
pandemic H1 strain (A(H1N1)pdm09). Thus, a positive result on swIAV are reported as either 
“swIAV” if the general swIAV assay was positive and “H1 (A(H1N1)pdm09)” if both assays were 
positive for a given sample. 
 
Individual herd analysis 
Herd 1: nursery (1N) and finisher (1F) pigs (Supplementary table 1A and B) 
In herd 1, three age groups were sampled in the nurseries, whereas only two age groups were 
sampled in the finishers due to continuous flow and no clear separation of age groups. In the early 
nursery period, coughing episodes were often observed, but a coughing event was only recorded in 
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one pen (marked with green in Supplementary table 1A). In the affected pen, swIAV, PCMV and A. 
pleuropneumoniae were detected. swIAV was detected in all age group in the nurseries, while it 
was only found sporadically in the finishers. A. pleuropneumoniae was found in all pens in October 
and November 2017 in the finishers, while it was only found in single pens in the other samplings. 
PCMV and S. suis type 2 were found to circulate in both nurseries and finishers in all pens. 
Furthermore, M. hyorhinis was detected in almost all pens. In general, piglets generally seemed 
small at weaning in this herd.  
     Seventeen diarrhoeic events (marked with red in Supplementary table 1A and 1B), distributed 
between the nurseries and finishers, although clinical diarrhoea was only observed in few pens after 
weaning. In general, E. coli F4 and E. coli F18 were detected in the beginning of the nursery period 
in all three months, while L. intracellularis was detected at the end of the nursery period. Rotavirus 
A was also present in several of the nursery pens. However, no clear association was observed 
between the presence of pathogen and diarrhoeic events. In the finisher pens, clinical diarrhoea was 
observed in almost all pens although intestinal pathogens were only detected in few of them.  
 
Herd 2: nursery pigs (2N) (Supplementary table 1C) 
It was not possible to collect oral fluid samples from the youngest pigs in November due to their 
lack of interests in chewing in the rope. Three coughing events (marked with green in 
Supplementary table 1C) were registered in this herd, all in the early nursery period in September 
and October. In these pens, swIAV and PCMV were detected with low Cq values. S. suis type 2 
was circulating in all pens, while PCMV, PCV2, PCV3, M. hyorhinis and A. pleuropneumoniae 
were detected in many of the pens. Furthermore, four diarrhoeic events (marked with red in 
Supplementary table 1C) were detected in herd 2 and L. intracellularis was found in all four 
affected pens. Rotavirus A was found in nearly all pens, whereas E. coli F4 and E. coli 18 were 
found to be most prevalent in the beginning of the nursery period. L. intracellularis was found in 
the mid and late nursery period with lowest Cq values in November. In this herd, newly weaned 
pigs were fed liquid feed and extra water in troughs to optimize weaning, which may contribute to 
the low levels of intestinal pathogens and clinical diarrhoea observed in general. 
 
Herd 3: nursery (3N) and finisher (3F) (Supplementary table 1D and 1E) 
Coughing events were detected in two pens in the nurseries (marked with green in Supplementary 
table 1D). PCMV was detected in nearly all pens, but the virus was found with the lowest Cq values 
Own studies – Manuscript III 
 87
in the affected pens. swIAV, which was found in one of the affected pens and was detected with 
low Cq values in the beginning of the nursery period in September and October, whereas in 
November it was detected in the middle to late nursery period. In contrast, swIAV was only 
detected sporadically in the finishers. PCV3, M. hyorhinis and S. suis type 2 were also detected in 
many of the pens. Four diarrhoeic events (marked with red in Supplementary table 1D) were 
registered in the nursery pens and eight diarrhoeic events (marked with red in Supplementary table 
1E) were registered in the finishers. No clear pattern was observed for the findings of B. pilosicoli, 
L. intracellularis, E. coli F4 and E. coli 18, which were all detected sporadically in all age groups. 
Furthermore, no clear pattern between the pens affected by diarrhoea and the findings of pathogens 
was observed.  
 
Herd 4: nursery (4N) and finisher (4F) pigs (Supplementary table 1F and 1G) 
Clinically, no coughing events were observed in this herd during the three sampling months. This is 
in line with the finding that swIAV did not seem to cause problems in this herd. Between the 
samplings in October and November, the veterinarians experienced clinical signs of wasting and 
uneven weight distribution 15-25 days after arrival to the nursery. Multiple factors could be the 
reason for this. PCV2 was found in all age groups and with low Cq values in the finishers, and 
therefore, this virus could potentially have had an impact on productivity and secondary infections. 
Furthermore, M. hyorhrinis, B. bronchiseptica and PCV3 were found sporadically in the nurseries 
and finishers. Fifteen diarrhoeic events were observed (marked with red in Supplementary table 1F 
and 1G). E. coli F4 and E. coli F18 seemed to be a problem in the early nursery period. B. 
pilosicoli, sometimes in combination with L. intracellularis, dominated in the mid to late nursery 
period. Infections with B. pilosicoli and L. intracellularis seemed to extend to the finishing period. 
In November, all pens in the nurseries were positive for diarrhoeic events, which coincided with 
detection of E. coli F4 and E. coli F18 20 days after weaning. In addition, findings of B. pilosicoli 
and L. intracellularis 34 and 48 days after weaning could also explain the symptoms observed. In 
the finishers, detection of B. pilosicoli and L. intracellularis, both separately and in combination, 
generally correlated with diarrhoeic events. Rotavirus A was primarily detected in September and 
October in the nurseries.  
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Herd 5: nursery pigs (5N) (Supplementary table 1H) 
One coughing event was detected in this herd (marked with green in Supplementary table 1H) and 
the affected pen was positive for swIAV and PCMV. Furthermore, coughing was noticed with high 
frequency in the youngest age group in all three months, even though it was not correlated to 
coughing events. In general, swIAV was detected with low Cq values at 12-15 days after weaning 
and with higher Cq values in the late nursery period in September and October. PCVM, S. suis type 
2 and M. hyorhrinis were detected in all pens, while PCV2 was detected in almost all pens. Several 
pens were also positive for PCV3 and B. bronchiseptica. Diarrhoea was rarely observed and only 
one diarrhoeic event was observed (marked with red in Supplementary table 1H). In the affected 
pen, B. pilosicoli was detected with a low Cq value. L. intracellularis and rotavirus A were also 
present, but with higher Cq values. Rotavirus A was found in all most all pens, while L. 
intracellularis only was found in the late nursery period in all three samplings. E. coli F4 and E. 
coli F18 were found mainly in the early to mid nursery period.  
 
Herd 6: nursery (6N) and finisher (6F) pigs (Supplementary table 1I and 1J) 
One coughing event was noticed in this herd in the mid nursery period in November (marked with 
green in Supplementary table 1I). In the affected pen, PCMV and A. pleuropneumoniae was 
detected and this pen was the only pen in the nurseries in which A. pleuropneumoniae was found. 
However, A. pleuropneumoniae was widely distributed in the finishers. PCMV was detected in 
many of the pens, but with the lowest Cq values in the nurseries. PCV2 and S. suis type 2 were 
detected in all pens except for one, and PCV2 was present with low Cq values in several of the pens 
with the majority in the finishers. swIAV was detected in all age groups in the nurseries and was 
also detected in the beginning of the finisher period. One of the sample collected in the nurseries in 
September, was positive for H1 (A(H1N1)pdm09). PCV3 was present in all age groups. Diarrhoea 
seemed to be a problem in this herd, since 28 diarrhoeic events (marked with red in Supplementary 
table 1I and 1J) distributed between the nurseries and finishers were observed. B. pilosicoli and L. 
intracellularis were mainly detected in the mid to late nursery period, while B. pilosicoli was found 
in every pen in the finishers and here L. intracellularis was only found in beginning of the period. 
E. coli F18 was detected in the nursery pigs 15-17 days after weaning in the three months, while E. 
coli F4 was only present in November. 
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Pathogen findings and clinical signs 
This section describes the presence and dynamics of pathogens across the herds and, when relevant, 
the correlation between pathogens and coughing events or diarrhoeic events was calculated.  
 
Swine influenza A virus  
swIAV was detected in all herds with an overall prevalence of 34.9%. The infection patterns varied 
between the herds and age groups. For most of the herds, swIAV was present shortly after weaning, 
and only sporadically later in the nursery period. In the finishers, only a few pens were found 
positive and mainly in the beginning of the period. Six out of eight pens, in which coughing events 
were registered, were found to be positive for swIAV and a significant correlation between 
coughing events and swIAV detection were found (p = 0.02). Furthermore, to investigate whether 
the level of swIAV correlated to the coughing events different cut-off Cq values were tested (Table 
2). No significant correlation between coughing events and the level of swIAV was found with cut-
off values of Cq 16 (p = 0.08) and 18 (p = 0.10), while with a cut-off value of Cq 20 a significant 
correlation was observed (p = 0.03). The Cq values for all the positive swIAV findings are plotted 
in Figure 2.  
 
Porcine cytomegalovirus  
PCMV was detected in almost all pens in all herds and had an overall prevalence of 92.4%. In 
general, the detection of PCMV was highly consistent with the lowest Cq values in the early to mid 
nursery period and with higher Cq values in the samples collected from six to eight weeks after 
weaning and until slaughtering (Figure 3). PCMV was detected in the eight pens in which coughing 
events were registered with Cq values between 8.0 and 16.3. Furthermore, there was a significant 
relationship between the level of PCMV and coughing events with cut-off Cq values of 16 (p = 
0.0001), 18 (p = 0.002) and 20 (p = 0.02), while no significant correlation was observed with a cut-
off value of 22 (p = 0.21) (Table 2). The Cq values for all the positive findings of PCMV are plotted 
in Figure 4. 
     In general, PCMV was present with lower Cq values in the pens with swIAV. Furthermore, 
PCMV with Cq value ≤ 20 was also detected in the six “coughing event” pens, which were positive 
for swIAV, and a significant correlation between these two viruses and coughing event was found 
(p = 0.004).      
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Porcine circovirus type 2  
PCV2 was detected in all herds, but with different patterns. The virus was detected in the oral fluid 
samples in 59.9% and in 40.2% of the faecal sock samples. PCV2 was detected in four of the 
“coughing event” pens with Cq values  23, and no significant correlation between detection of 
PCV2 and coughing event was observed (p = 0.72). Since it has been showed that PCV2 can be 
related to intestinal disease the association with diarrhoeic events was also investigated (Segalés et 
al., 2005). PCV2 was detected in 41.6% of the pens, where diarrhoeic events were observed with 
Cq values between 10.2 and 27.5. No significant correlation was observed between the presence of 
PCV2 and diarrhoeic events (p = 0.87), even when using different cut-off values (Table 3). 
 
Porcine circovirus type 3 
PCV3 was detected in all herds with the majority of Cq values above 20. The virus was detected 
sporadically in most of the herds, but more frequently in herd 3. In the oral fluid samples, the 
overall prevalence of PCV3 was 53.5%. For the faecal sock samples, it was 16.1%. PCV3 was 
detected in five of the “coughing event” pens, where four of the pens had Cq values above 25, while 
the last one had a Cq value of 19, and no significant correlation was observed between the presence 
of PCV3 and coughing events (p = 0.73). PCV3 was also detected in 16.1% of the faecal sock 
samples and was present in 16.9% of the pens, where diarrhoeic events were registered, with Cq 
values above 23. 
 
Actinobacillus pleuropneumoniae 
A. pleuropneumoniae was detected in five of the ten herds with an overall prevalence of 17.4%. A. 
pleuropneumoniae was found in three of the eight pens, where coughing events were observed, with 
Cq values above 24. There was no significant correlation between A. pleuropneumoniae positive 
pens and coughing events (p = 0.15). 
 
Mycoplasma hyohrinis  
M. hyohrinis was frequently detected in herds 1 to 5 with the majority of Cq values above 20, while 
it was not detected in herd 6. M. hyohrinis was detected with an overall prevalence of 59.3% and 
with a different detection patterns for the different herds. In herds 1N, 1F, 2N, and 5N almost all 
pens were positive, while a more sporadic distribution was found in herds 3N, 3F, 4N, and 4F. M. 
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hyorhinis was present in seven of the “coughing event” pens with Cq values above 20 and no 
significant correlation between M. hyorhinis detection and coughing event was found (p = 0.08). In 
Figure 5, Cq values from the positive samples were plotted and a decrease in Cq values was 
observed during the three months, with the highest mean Cq in September (25) and the lowest mean 
Cq in November (23). An one-way ANOVA test confirmed that the mean Cq values for the three 
months were not equal. Furthermore, a t-test analysis showed that there was a significant difference 
between the mean Cq values for the three months: September and October (p = 0.03), October and 
November (p = 0.01) and September and November (p = 0.00001).  
 
Streptococcus suis type 2  
S. suis type 2 was detected in all herds with an overall prevalence of 98.8%. S. suis type 2 was 
found in all eight pens in which coughing events were observed with Cq values above 21. No 
significant correlation was found between S. suis type 2 detection and coughing event (p = 0.91). 
 
Mycoplasma hyopneumoniae, Bordetella bronchiseptica and Pasteurella multocida 
M. hyopneumoniae was only found in two pens (1.2%) and both in herd 6F in the sampling from 
October. B. bronchiseptica and P. multocida were detected sporadically with the prevalence of 
25.0% and 15.1%, respectively. However, none of these bacteria were detected in pens with 
coughing events. 
 
Brachyspira pilosicoli 
B. pilosicoli was found with an overall prevalence of 39.7% and was generally found from mid 
nursery to late finishers period. B. pilosicoli was detected in all herds except for herd 1, and 
furthermore was present in 37 (48.1%) of the tested pens, in which diarrhoeic event was also 
observed. A significant correlation between diarrhoeic events and the presence of B. pilosicoli was 
observed when using a cut-off Cq value ≤ 26 (p = 0.03) (Table 3). 
 
Lawsonia intracellularis 
L. intracellularis was detected with an overall prevalence of 40.8% and was found mainly in the 
mid to late nursery and finisher period. L. intracellularis was detected in 37 (48.1%) of the pens, 
where diarrhoeic event was observed. For L. intracellularis, a significant correlation between the 
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presence of the bacterium and diarrhoeic events was found when using a cut-off Cq value ≤ 24 (p = 
0.01) (Table 3).  
 
Escherichia coli F4 and F18 
E. coli F4 and E. coli F18 were detected in 19.0% and 28.7% of the pens, respectively, and mainly 
in the beginning of the nursery period, although a sporadic detection was also observed in the 
finishers. In general, E. coli F18 was detected more frequently than E. coli F4 in the herds except 
for herds 2N and 4N. E. coli F4 was present in 12 (15.6%) of the tested pens, in which diarrhoeic 
event was also observed, while for E. coli F18 the number of pens was 16 (20.8%). For both E. coli 
F4 and E. coli F18, no significant correlation was found to pens with diarrhoeic events (p = 0.43 
and p = 0.06, respectively), even when using different cut-off Cq values (Table 3). 
 
Rotavirus A 
Rotavirus A was detected in all herds with an overall prevalence of 54.0%. In general, rotavirus A 
was most frequently detected in the beginning of the nursery period, in which also the lowest Cq 
values were found. In the youngest age group of the nurseries, only one pen (herd 4N) was 
negative. In the finishers, Rotavirus A was only detected sporadically. The virus was detected in 29 
(37.7%) of the pens, where a diarrhoeic event was observed. No significant correlation between the 
presence of rotavirus A and diarrhoeic events was found when using a cut-off Cq value ≤ 20 (p = 
0.3), however, a significant correlation was observed when using Cq values above  22 (p = 0.009) 
(Table 3). 
 
Discussion 
In the present study, three monthly samplings were conducted in six nursery and four finisher herds 
to investigate the value of continuous screening for selected respiratory or enteric viral and bacterial 
pathogens in different age groups. Oral fluid and faecal sock samples were collected and analysed 
using the high-throughput diagnostic system described elsewhere (Goecke et al., 2018). The use of 
a high-throughput qPCR platform, in which multiple samples can be analysed in different assays 
simultaneously, provides new possibilities for conducting extended diagnostics at a limited cost. 
The aim of the present study was to investigate the pathogen patterns in ten herds over time and 
compare the findings with the observed clinical signs of coughing and diarrhoea. 
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     The vision of the diagnostic system tested in the present study, was that the herd consultant 
includes the results of the diagnostic screenings as a tool in the herd health management by 
benchmarking the monthly data on the presence and dynamics of pathogens with figures on 
productivity, feed consumption/feed plans, clinical symptoms and antibiotic consumption. By that 
the herd consultant will be able to identify the underlining course of impaired production figures or 
health. Furthermore, in case of acute outbreak of clinical disease or sudden change in performance, 
samples are often submitted for diagnostic examinations; however, the results of these tests are 
often difficult to interpret because most of the potential pathogens are often circulating in herds 
without clinical impact. If screening of the herd had been performed during the months prior to the 
acute outbreak, the “outbreak” results can be compared to these herd-specific historical data and by 
that identify if a given pathogen has been introduced or has changed dynamics. In all of the ten 
herds included in the present study, the screening data identified unexpected pathogen patterns and 
by that identified potential targets for preventive measures to increase the health and/or 
productivity. 
 
In herd 1, swIAV was circulating in the herd in all age groups, which was probably due to the 
continuous flow of pigs in the nursery rooms and/or the continuous production of finishers without 
washing and disinfection of pens between batches. Only new gilts and gilts prior to farrowing were 
vaccinated against swIAV (Respiporc FLU3, IDT), however, vaccination of piglets should be 
considered based on the screening results. Furthermore, E. coli F4 and E. coli F18 were often 
detected in this herd without correlation to disease. However, enteritis can be present in a herd 
without causing clinical signs (Weber et al., 2017), and therefore, vaccination targeting E. coli for 
nursery pigs may be beneficial.  
     In herd 2, swIAV was present in all age group with low Cq values but the H1 (A(H1N1)pdm09) 
strain was not detected at any sampling point. The herd vaccinated against A(H1N1)pdm09 
(FluSure pandemic, Zoetis), but this vaccine does not cross protect against enzootic Danish 
swIAVs, and therefore, vaccination against other swIAV subtype(s) could be effective in this herd.  
     In herd 3, there was a long-term history of swIAV infection and, therefore, an intensive 
vaccination protocol was carried out, in which piglets, new gilts, gilts and sows were vaccinated 
(Respiporc FLU3, IDT). Despite the vaccination, swIAV was still found to be present in the early to 
mid nursery period and in the finishers 14-16 days after arrival. The continued circulation of swIAV 
could be due to infection with a heterologous subtype(s) not included in the vaccine or a short-term 
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effect of the piglet vaccination. Therefore, a subtyping of the circulating swIAV subtype(s) should 
be carried out to determine if the applied vaccine is specific enough. Furthermore, it could be 
considered to vaccinate sows 3-4 times a year to ensure high levels of immunity in the sow herd.  
     In herd 4, the enteric pathogens E. coli F4, E. coli F18, B. pilosicoli and L. intracellularis were 
detected in several of the pens. In addition, PCV2 was present in all age groups, and especially in 
the finisher. Furthermore, the average weight gain in the finishers were below the Danish national 
average. Thus, these data implies that PCV2 has a negative impact in this herd, and therefore, 
vaccination against PCV2 should be initiated.  
     In herd 5, a comprehensive vaccination protocol was applied against swIAV (Respiporc FLU3, 
IDT), including vaccination of piglets, new gilts before introduction, gilts and sows. Despite this 
vaccination regime, swIAV was still detected, which could indicate that the effect of vaccination 
was suboptimal. To address this, subtyping or sequencing of the circulating swIAV strains should 
be performed to secure that the vaccine elicited cross protection. Furthermore, the herd had a poor 
productivity (ADWG at 385 g/day) and the nursery mortality was 4%. PCV2 vaccination was 
performed at weaning, but still moderate levels of PCV2 were found in the youngest nursery pigs 
and therefore it cannot be excluded that PCV2 has an influence on the poor productivity. Thus, it 
may be beneficial in this herd to perform PCV2 vaccination at an earlier time point. 
     In herd 6, new gilts were vaccinated against A(H1N1)pdm09 (FluSure pandemic, Zoetis) and 
swIAV (Respiporc FLU3, IDT) before introduction. H1 (A(H1N1)pdm09) was detected in one pen, 
while other swIAV subtype(s) was found to be present sporadically in several of the pens, mainly in 
the nursery herd. Subtyping of the circulating swIAV subtype(s) should be performed to examine if 
the vaccination could be more effective. PCV2 was widely distributed in both the nurseries and 
finishers and in levels which could cause systemic disease and lead to decreased productivity 
(Segalés, 2012). Vaccination against PCV2 was not applied in this herd, but based on the findings 
in the present study, vaccination before weaning could be considered to control PCV2.  
     M. hyopneumoniae was detected in two pens in the finisher herd despite vaccination. In the 
finishers, a mortality rate of 4.5% was found based on the data from the productivity report. The 
mortality could be due to concurrent circulation of several pathogens, but more investigations are 
needed to confirm this. A high stocking density was often noticed during the samplings, which 
could contribute to the on-going circulation of these pathogens. High occurrence of diarrhoea 
seemed to be a clinical issue in both nurseries and finishers with a clear pattern. E coli F4 and/or E 
coli F18 were found in the beginning of the nursery period followed by L. intracellularis and B. 
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pilosicoli, which persisted until slaughter. Common practise in this herd was to use water 
medication pen wise, however, an extension to batch medication may be more effective. 
Furthermore, focus should be on optimizing diets, hygiene, stocking density in the finishers. E. coli 
F4 and E coli F18 vaccination could be considered. 
 
The coughing events observed in the present study seemed to correlate with the presence of swIAV 
(p = 0.02) or PCMV (Cq ≤ 20) (p = 0.02) or a combination of these (p = 0.004). The correlation 
between coughing and isolation of swIAV has been shown in another study which used the same 
cut-off for coughing events (Tolstrup et al., 2017). However, the clinical effects of PCMV are not 
clear and a cut-off Cq value was also needed in the present study in order to obtain a significant 
correlation to coughing events. To our knowledge, co-infection with swIAV and PCMV has not 
previously been described, and further studies are needed to support this finding. However, the 
correlation between coughing events and the presence of pathogen was based on a few coughing 
events, which makes it difficult to make clear conclusions.  
     swIAV was detected in all the tested herds, and all herds, except for herd 4, vaccinated against 
swIAV using different vaccination strategies. Among the herds, different infection patterns were 
observed, however, the most typical pattern was high levels of swIAV just after weaning, which 
could indicate poor immunity. The lack of immunity may be explained by short-term duration of 
maternal immunity or reduced effect of vaccination. The reduced effect of vaccination might be due 
to the high evolution rate of swIAV, which is able to undergo changes doing antigenic drift or shift. 
As a consequence, the swIAV strain is no longer recognized by the vaccine as it will differ from the 
swIAV strains included in the vaccine (Carrat and Flahault, 2007; Zambon, 1999).  
     PCV2 was found with a high prevalence in herds 4F, 5N, 6N, and 6F. Although no correlation to 
neither coughing nor diarrhoeic events was evident, PCV2 might still act sub-clinically. 
Furthermore, reasonable good management practise was seen in all herds which, combined with 
high health status, could minimize the impact of PCV2. The role of PCV2 in PRDC is still up for 
discussion. Studies suggest that PCV2 lung lesions do not exist without systemic infection and may 
only participate in PRDC sub-clinically (Raith et al., 2015; Ticó et al., 2013). This could explain the 
missing correlation between PCV2 and clinical respiratory signs in the present study. Furthermore, 
a study suggested that PCV2 is more often found in connection with PRRSV than with swIAV and 
M. hyopneumoniae (Harms et al., 2002), however, PRRSV was not detected in this study.  
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     PCV3 is a novel discovered virus and only a limited number of studies are available. The current 
study is to our knowledge the first to demonstrate the wide distribution of PCV3 in Danish pig 
herds. PCV3 was found in all age groups in both nurseries and finishers and was primarily detected 
with relatively high Cq values. Furthermore, it did not correlate to events of respiratory disease.  
 
There is sparse documentation on the predictive value of detecting bacteria in oral fluid samples and 
therefore oral fluid is recommended only as a screening tool and the detection of these bacteria 
should be confirmed by traditional diagnostic tests (i.e. culturing from lungs of dead pigs).  M. 
hyorhinis, S. suis type 2, B. bronchiseptica, and P. multocida are all considered to be secondary 
invaders in relation to PRDC and commensals present in both healthy and diseased pigs. In this 
study, S. suis type 2 and M. hyorhinis were indeed detected with relatively high Cq values in all 
pens (except herd 6 for M. hyorhinis) and no clinical signs could be correlated to the detection of 
these two pathogens. B. bronchiseptica and P. multocida were found more sporadically. These 
bacteria were also detected with high Cq values and they were not found in relation to clinical 
disease. Interestingly, the mean Cq values of M. hyorhinis differed significantly between all three 
sampling months, with the highest Cq mean recorded in September and the lowest Cq mean in 
November. This could indicate a seasonal variation in the infection pressure of M. hyorhinis 
although the clinical effect is unknown. A benefit of continuous health monitoring could potentially 
be the detection of such seasonal variances for more of the analysed pathogens if evaluated for an 
extended period. 
     A. pleuropneumoniae and M. hyopneumoniae act as primary pathogens, providing optimal 
conditions for secondary pathogens. A. pleuropneumoniae was only found in the oral fluids in herds 
already declared positive and was only detected with high Cq values, which could indicate that 
carrier animals harboured A. pleuropneumoniae in the tonsils. Another explanation could be that the 
sensitivity of detecting A. pleuropneumoniae by PCR in oral fluid compared to lungs is considered 
low (Gottschalk, 2015). However, the bacterium was not detected in correlation to clinical signs in 
this study. M. hyopneumoniae was rarely detected in this study. A study found limited sensitivity of 
detecting M. hyopneumoniae in oral fluid, which could lead to an underestimation in positive pens 
(Hernandez-Garcia et al., 2017).  
     For some of the herds, a clear pattern of enteric pathogens was observed, in which E. coli F4 
and/or E. coli F18 were present in the early nursery period, L. intracellularis in the mid nursery to 
early finishing period and B. pilosicoli in the late nursery to late finisher period. This distribution of 
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these bacteria is comparable to others findings (Jacobson et al., 2003; Stege et al., 2000; van Beers-
Schreurs et al., 1992). For other of the herds, no specific pattern was found. Diarrhoeic events 
observed in the present study seem to be associated with different bacteria in different age groups 
and with a similar pattern. However, no significant correlation between diarrhoeic events and the 
presence of E. coli F4 and E. coli F18 was found. On the other hand, a significant correlation was 
observed for L. intracellularis (Cq ≤ 24) and B. pilosicoli (Cq ≤ 26). Furthermore, rotavirus A was 
detected in all herds and especially in the nurseries. This virus is known to be endemic in pig herds 
and has been associated with acute gastroenteritis in young animals (Saif and Fernandez, 1996). In 
the present study, rotavirus A was found in several of the pens affected by diarrhoeic events, 
however, a significant correlation between diarrhoeic event and the presence of the virus was only 
observed when including Cq values above 22 (p = 0.009). Due to the fact that Rotavirus A only 
seems to pose a problem when including the high Cq values, this virus was probably not the cause 
of diarrhoea in the affected pens. 
     Diarrhoeic events were also observed in pens where no intestinal pathogens were found 
indicating that the course was non-infectious or caused by pathogens, which were not included in 
the high-throughput analysis. Another study found that approximately 50% of the investigated pigs 
suffering from diarrhoea were negative for pathogenic intestinal bacteria when using qPCR (Weber 
et al., 2015).  
     In general, the findings in the present study were based on Cq values, which gives an indication 
of how positive the sample is. However, quantitative measurements of pathogen load, including e.g. 
copies/g faeces, will provide a more informative result, since it may be able to differentiate a 
colonisation pathogen from a disease causing pathogen (Yang and Rothman, 2004). For several of 
the intestinal bacteria, cut-off values have been proposed (Pedersen et al., 2014), and these values 
can be used to examine if a given bacteria is the main reason for the observed clinical disease or 
not.  
 
In conclusion, the use of high-throughput qPCR analysis for monthly monitoring of pathogens and 
thereby dynamics of pathogens in a pig herd, provides the veterinarian and farmer with an objective 
knowledge on the distribution of pathogens in the herd. In addition, the use of a high-throughput 
method in combination with information about clinical signs, productivity, health status and 
antibiotic consumption, presents a new and innovative way of diagnosing and monitoring pig herds 
and even to a lower cost than the traditional method. Furthermore, this continuous monitoring of 
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pathogens in Danish pigs provide a tool for optimized preventive measures and by that could 
contribute to a reduction of antibiotic consumption.   
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Table 1 Information and vaccination strategies for each of the herds. N: nursery, F: finisher   
 1N 1F 2N 3N 3F 4N 4F 5N 6N 6F 
SPF status Unknown Unknown Blue + AP12 Blue Blue Blue + M. 
hyo 
Blue + M. 
hyo 
Blue + M. 
hyo 
Blue + M. hyo+ 
AP12 
Blue + M. hyo+ 
AP12 
swIAV status Not 
diagnosed 
Not 
diagnosed 
Positive + 
A(H1N1)pdm09 
Positive Positive Positive Positive Positive Positive + 
A(H1N1)pdm09 
Positive + 
A(H1N1)pdm09 
Sows per year 400 400 770 560 560 - 2,500 2,500 735 730 
No. of pen units 1,800 600 3,000 1,500 + 
1,400 
? 2,020 2,880 2,500 ? 1,700 
No. of produced 30 
kg pigs per year 
13,500 - 33,000 19,000 (sell 
5500 per 
year) 
- 20,000 - 80,000 23,500 - 
No. of produced 
finishing pigs per 
year 
- 4,000 - - 13,500 - 12,300 - - 6,000 
Type of farm Full-line Full-line Full-line Full-line Full-line Nursery and 
finishers 
Nursery and 
finishers 
Sows and 
nursery 
Full-line Full-line 
No. of sites 1 nursery site 
(total 1) 
1 finisher site 
(total 1) 
2 nursery sites 
(total 7) 
2 nursery 
sites (total 3) 
2 finisher 
sites (total 3) 
1 nursery 
site (total 3) 
3 finisher 
sites (total 3) 
2 nursery 
sites (total 3) 
1 nursery site 
(total 1) 
1 finisher site 
(total 1) 
Production Weekly Weekly Weekly Every 14
th 
day 
Every 14th 
day 
Every 14th 
day 
Every 14th 
day 
Weekly Weekly Weekly 
Vaccination status 
Erysipelothrix 
rhusiopathiae  
+         
Erysipelothrix 
rhusiopathiae +  
parvovirus 
+ + +   + + 
Glässers disease (H. 
parasuis) 
+         
swIAV +  +   + + 
A(H1N1)pdm09   +      + 
M. hyopneumoniae   +   +  + 
PCV2    +   +   
E. coli + C. 
perfringens 
+ + +   + + 
E. coli F4/F18   + +      
1
0
2
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Table 2 p-values (Fishers exact probability test) calculated for different cut-off Cq values for respiratory viruses 
Coughing event +/- Cq ≤ 16 Cq ≤ 18 Cq ≤ 20 Cq ≤ 22 
p-value (swIAV) 0.02 0.08 0.10 0.03 na 
p-value (PCMV) 0.53 0.0001 0.002 0.02 0.21 
na: no analysis 
 
 
Table 3 p-values (chi-square test) calculated for different cut-off Cq values for the intestinal pathogens  
 
Diarrhoeic event +/- Cq ≤ 16 Cq ≤ 18 Cq ≤ 20 Cq ≤ 22 Cq ≤ 24 Cq ≤ 26 Cq ≤ 27 
p-value (PCV2) 0.87 0.30 0.48 0.08 0.14 na na na 
p-value (B. pilosicoli) 0.06 na 0.005 0.001 0.007 0.004 0.03 0.06 
p-value (L. intracellularis) 0.12 na 0.006 0.008 0.03 0.01 0.91 na 
p-value (E. coli F4) 0.43 na na 0.82 0.43 na na na 
p-value (E. coli F18) 0.06 na na na 0.82 0.58 na na 
p-value (Rotavirus A) 0.0002 na na 0.3 0.009 0.007 na na 
na: no analysis 
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Figure 1 Schematic illustration of how age groups and pens were selected. Here, a nursery herd is used as an example. FS: faecal 
sock sample, OF: oral fluid sample. 
 
 
 
Figure 2 Cq values for each positive swIAV sample are plotted for each of the three sampling months (negative pens are not shown).  
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Figure 3 The reverse Cq values for the positive PCMV samples from all the pens are plotted. The samples are listed from youngest 
to oldest. A, B and C refer to the youngest, mid and oldest pigs, respectively, in both nurseries (N) and finishers (F). The y-axis 
shows the reverse Cq values. 
 
 
 
Figure 4 Cq values for each positive PCMV sample are plotted for each of the three sampling months (negative pens are not shown). 
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Figure 5 Cq values for M. hyohrinis positive sample are plotted for each of the three months (negative pens are not shown).  
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Supplementary tables  
 
A) 1N – oral fluid (OF) and faecal sock (FS) samples  
Sampling date September October November 
Days after insertion 10 25 45 19 26 47 10 24 45 
Pathogen  Material Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 
swIAV OF 11.4 14.5 25.7      24.4  23.6  24.1 24.9 15.1 19.2  23.9 
H1 (A(H1N1)pdm09) OF                   
PRRSV type 1 OF                   
PRRSV type 2 OF                   
PCMV OF 15.8 12.7 14.6 12.5 22.1 21.2 12.1 13.5 17.0 14.7 19.9 19.6 11.8 16.3 13.7 17.3 18.0 22.4 
A. pleuropneumoniae OF     24.4         26.8     
PCV2 OF       27.5  21.6      27.0  23.3  
S. suis type 2 OF 22.5 22.8 26.2 26.6 21.9 22.2 24.4 22.6 22.9 23.6 24.3 23.22 24.6 21.1 23.1 24.4 17.4 19.6 
B. bronchiseptica OF     25.9    27.7  25.5        
PCV3 OF   26.6    25.1 24.8     17.3 18.7 27.9   30.0 
PPV OF                   
M. hyopneumoniae OF                   
M. hyorhinis OF  26.6 28.8 27.3 27.5  23.8 23.9 25.7 25.3 25.9 24.3 26.8 21.8 26.8 24.8 22.7 23.7 
P. multocida OF         29.9 29.8       27.9  
B. pilosicoli FS                   
L. intracellularis FS     19.2 21.1     25.0 22.8     17.0  
E. coli F4 FS  23.5    27.4  17.6     20.6 19.9     
E. coli F18 FS 18.2 21.2     20.8 15.6     16.4 15.5     
PCV3 FS             23.5 26.7     
PCV2 FS         26.9        27.5  
Rotavirus A FS 27.9 27.4   30.5  21.2 17.4  22.9   17.7 17.1 24.6 21.5 29.7  
1
0
7
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B) 1F – oral fluid (OF) and faecal sock (FS) samples  
Sampling date September October November 
Days after insertion ? (45-80 kg) ? (80-100 kg) ? (45-60 kg) ? (50-85 kg) ? (65 kg) ? (75-80 kg) 
Pathogen  Material Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 
swIAV OF        24.9 20.3 27.1   
H1 (A(H1N1)pdm09) OF             
PRRSV type 1 OF             
PRRSV type 2 OF             
PCMV OF 21.3 24.8 21.7 22.5 24.6 18.0 21.7 24.3 22.2 18.7 20.5 18.8 
A. pleuropneumoniae OF    23.9 24.3 22.9 24.8 22.2 22.9 22.9 23.1 22.8 
PCV2 OF  24.7  25.0        25.7 
S. suis type 2 OF 22.5 22.9 22.1 21.3 24.6 22.7 22.0 21.5 19.8 20.2 20.6 21.1 
B. bronchiseptica OF             
PCV3 OF   27.1 26.3    27.5 27.3 30.2  31.4 
PPV OF             
M. hyopneumoniae OF             
M. hyorhinis OF 26.0 28.8 25.1 26.5 27.4 26.0 26.6 27.9 19.6 21.8 23.5 25.2 
P. multocida OF     30.4   29.2     
B. pilosicoli FS             
L. intracellularis FS      21.8 25.0      
E. coli F4 FS             
E. coli F18 FS     24.6 24.7 24.8      
PCV3 FS             
PCV2 FS             
Rotavirus A FS  26.4   24.5 31.4  27.1     
1
0
8
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C) 2N – oral fluid (OF) and faecal sock (FS) samples  
Sampling date September October November 
Days after insertion 9 37 65 10 24 38 2 29-36 48 
Pathogen  Material Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 
swIAV OF 14.9 14.2  18.6   12.8 12.2 15.4 14.9 22.7 27.6    15.7 25.6 24.0 
H1 (A(H1N1)pdm09) OF                   
PRRSV type 1 OF                   
PRRSV type 2 OF                   
PCMV OF 8.0 10.7 18.7 18.0  20.6 11.2 10.2 13.1 13.4 19.5 18.2   17.8 18.8 22.8 17.9 
A. pleuropneumoniae OF       24.0 24.3 24.4 25.2 24.7     23.4   
PCV2 OF 24.6  18.7 20.3 14.9 14.6     26.9    26.0   21.8 
S. suis type 2 OF 23.4 23.2 21.8 23.3 23.6 22.3 21.3 21.8 19.7 21.6 22.0 21.4   21.2 21.9 23.3 23.8 
B. bronchiseptica OF    25.7       26.6 25.8   25.6    
PCV3 OF   26.6 23.7 19.5 26.8   20.4 22.8     22.3 27.6 29.7 28.8 
PPV OF 26.2 27.4  25.76 18.7 17.9 28.4 30.3   27.1 30.7    32.3   
M. hyopneumoniae OF                   
M. hyorhinis OF 26.3 25.9 26.3  23.9  25.8 23.2 21.4 23.2 24.7 24.5   22.0 24.9 24.7  
P. multocida OF       25.4  19.4       34.8   
B. pilosicoli FS               21.6    
L. intracellularis FS   21.6 20.5 20.7 16.8   24.9 26.2 22.4 15.4   12.1 10.2 19.0 18.8 
E. coli F4 FS 20.7 24.1     21.9 22.0     14.6 15.3     
E. coli F18 FS 22.8      24.0 26.6 24.2          
PCV3 FS     27.9        24.9 23.1     
PCV2 FS     15.7 16.2             
Rotavirus A FS 26.1 19.1 30.5 32.9 29.7  22.9 21.2 21.0 17.9 29.7  13.5 13.1 24.2 23.2 21.0 15.7 
 
 
1
0
9
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D) 3N – oral fluid (OF) and faecal sock (FS) samples  
Sampling date September October November 
Days after insertion 10 24 38 12 26 40 16 30 45 
Pathogen  Material Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 
swIAV OF 13.0 24.0   26.1  13.5 14.9       22.5 13.2 11.7 21.4 
H1 (A(H1N1)pdm09) OF                   
PRRSV type 1 OF                   
PRRSV type 2 OF                   
PCMV OF 14.2 14.0 17.5 11.3 16.7 20.1 15.0 11.5 12.2 14.4 18.2 17.3 11.4 10.9 10.8 14.0 20.2 21.4 
A. pleuropneumoniae OF                   
PCV2 OF             23.4  25.3    
S. suis type 2 OF 20.0 24.1 24.2 22.3 24.3 22.6 18.9 19.4 21.4 22.6 20.7 19.5 21.8 22.6 22.4 24.5 21.8 22.3 
B. bronchiseptica OF 23.1    26.3  25.6 28.5 27.5  26.3  28.1   27.7   
PCV3 OF 16.4 26.8 26.7 27.4 25.9  28.9 19.6 27.6 21.9 21.9 26.4  26.2 25.8  24.2 25.0 
PPV OF                   
M. hyopneumoniae OF                   
M. hyorhinis OF   25.6 21.8 23.7 22.9 25.2    22.6 21.1 17.9 20.9 22.0 23.0 24.9 21.1 
P. multocida OF       24.9 26.6 27.9 30.0         
B. pilosicoli FS        21.6 17.2 23.3  26.5   18.6 19.6  19.3 
L. intracellularis FS     23.6     21.4 16.9  21.1  26.8  15.8 15.3 
E. coli F4 FS 22.4           17.2     25.4  
E. coli F18 FS 15.9 19.8  24.8    25.3 20.9   21.2 22.1  27.7   18.9 
PCV3 FS 24.0 24.3      25.3   22.3        
PCV2 FS  25.7                 
Rotavirus A FS 24.0 22.9  25.4   19.4 21.0 26.4 23.7   19.4 23.0 25.7    
 
1
1
0
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E) 3F – oral fluid (OF) and faecal sock (FS) samples  
Sampling date September October November 
Days after insertion 15 35 70 14 44 64 16 46 70 
Pathogen  Material Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 
swIAV OF  25.7  24.2   18.3      22.8      
H1 (A(H1N1)pdm09) OF                   
PRRSV type 1 OF                   
PRRSV type 2 OF                   
PCMV OF 22.8 20.8 19.0 22.5   20.3 17.0  21.9 20.2 21.6 23.7 22.8 20.4  21.0  
A. pleuropneumoniae OF                   
PCV2 OF 20.2      21.8 26.0  16.8   19.7 23.1  28.5   
S. suis type 2 OF 22.4 21.9 21.6 20.4 23.9 25.1 21.2 21.9 23.4 23.9 21.5 21.3 24.2 25.8 27.7 23.3 21.4 24.3 
B. bronchiseptica OF       26.0      26.7      
PCV3 OF 16.5 18.5 26.4 20.0 24.9  25.2  29.0 22.8 17.0 24.4 30.8 28.8  28.5 21.2  
PPV OF 24.5 27.0     27.1      30.4 27.2     
M. hyopneumoniae OF                   
M. hyorhinis OF 24.5 23.6 25.7 25.1   20.2 21.6  27.9  25.2 20.6 22.9   26.0  
P. multocida OF                   
B. pilosicoli FS   21.4  20.0 15.9  25.0   23.6 23.4   17.5 22.0  20.5 
L. intracellularis FS 17.6   25.6   23.2 18.1      18.1 26.7    
E. coli F4 FS                   
E. coli F18 FS  19.2            20.6 31.0    
PCV3 FS 25.2 24.9 27.7 23.9 29.1 27.9   29.5 28.6 27.2        
PCV2 FS      25.5 27.9      24.2  27.5 27.5   
Rotavirus A FS  22.4 29.4   24.9  20.7     26.0 31.6     
1
1
1
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F) 4N – oral fluid (OF) and faecal sock (FS) samples  
Sampling date September October November 
Days after insertion 17 31 45 17 31 45 20 34 48 
Pathogen  Material Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 
swIAV OF    25.5               
H1 (A(H1N1)pdm09) OF                   
PRRSV type 1 OF                   
PRRSV type 2 OF                   
PCMV OF 13.2 17.8 15.0 11.5 18.3 17.6 19.8 17.1 13.3 12.4 15.6 18.2 16.1 16.0 16.3 13.7 20.8 21.0 
A. pleuropneumoniae OF                   
PCV2 OF 28.4 26.2  24.6   24.6 25.8 28.0 24.7  27.6 26.0   33.4 22.8 24.6 
S. suis type 2 OF 19.4 22.2 21.2 22.1 20.2 22.0 19.9 20.6 20.8 22.4 20.8 20.0 22.3 22.1 20.6 20.2 21.1 21.8 
B. bronchiseptica OF 25.5 26.9 25.5 24.7 28.1 26.3   24.8         28.4 
PCV3 OF       27.3  24.7  27.5    24.0  25.9 31.0 
PPV OF                   
M. hyopneumoniae OF                   
M. hyorhinis OF 22.5 24.6 25.1    19.6 20.8 23.7 24.5 27.5 25.1  23.4 25.3  23.4 27.1 
P. multocida OF       27.9            
B. pilosicoli FS    17.7   27.2 24.9  25.0 17.5 17.6   18.1 14.7 16.0 15.5 
L. intracellularis FS      25.2           16.9 21.4 
E. coli F4 FS 23.8 25.6 19.9 23.6   21.9      17.3 17.2 27.4    
E. coli F18 FS 14.1 18.3     14.1 22.0 18.3    16.4 14.3     
PCV3 FS 26.5                  
PCV2 FS 27.2      26.7   28.3         
Rotavirus A FS 24.5 22.5 27.4 31.2 25.4 26.3 28.4 25.4 23.9    31.4      
1
1
2
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G) 4F – oral fluid (OF) and faecal sock (FS) samples  
Sampling date September October November 
Days after insertion 10 38 74 24 38 66 13 24 69 
Pathogen  Material Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 
swIAV OF      24.4             
H1 (A(H1N1)pdm09) OF                   
PRRSV type 1 OF                   
PRRSV type 2 OF                   
PCMV OF 17.0 18.4 22.3 21.6   22.0 19.3 26.4  23.7 23.2 19.8 18.3 20.4 22.0 23.6 20.1 
A. pleuropneumoniae OF                   
PCV2 OF 22.4 23.7 6.9 9.3 15.5 15.8 11.7 12.7 10.4 27.7 15.9 13.6 12.7 28.0 21.7  14.9 14.6 
S. suis type 2 OF 22.3 22.0 23.7 23.4 23.5 21.5 29.5 24.8 24.4  21.8 21.5 20.4 22.1 23.0 24.8 25.4 20.9 
B. bronchiseptica OF             25.7 27.6     
PCV3 OF    24.7  25.5   19.6   23.0 26.9      
PPV OF 27.3 28.0  27.7   29.1  16.8 23.5 23.3 25.0     21.2 25.9 
M. hyopneumoniae OF                   
M. hyorhinis OF 27.9 26.8      25.7 26.4  28.6  24.4      
P. multocida OF 25.7 23.7                 
B. pilosicoli FS  24.0 19.6 21.7  18.9   18.6 18.4 18.5 19.7 25.1 23.9   21.1 25.4 
L. intracellularis FS 24.5 16.9 17.9   25.3 18.4 14.3 21.2 26.6 24.0 27.2 15.7 15.0 22.2 16.9   
E. coli F4 FS            26.6       
E. coli F18 FS                   
PCV3 FS    24.7  25.5   24.8          
PCV2 FS 20.5 25.2 8.1 9.9 18.9 19.8 11.3 15.2 12.1 17.1 16.5 16.2 12.6  29.5  17.4 17.0 
Rotavirus A FS 22.0    27.8 27.2             
1
1
3
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H) 5N – oral fluid (OF) and faecal sock (FS) samples  
Sampling date September October November 
Days after insertion 12 33 46 12 33 46 15 29 43 
Pathogen  Material Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 
swIAV OF 11.6 10.4  21.0 28.0  17.0 15.8  20.1  25.6 12.1 10.6     
H1 (A(H1N1)pdm09) OF                   
PRRSV type 1 OF                   
PRRSV type 2 OF                   
PCMV OF 18.9 15.3 12.0 12.4 21.8 21.2 14.0 15.9 16.4 13.6 21.0 20.8 11.1 12.2 11.1 12.1 19.0 18.3 
A. pleuropneumoniae OF                   
PCV2 OF   24.9 20.9 21.4 23.2 19.9 11.5  23.8 17.8 19.2 21.5 23.1 17.8 13.6 19.6 15.9 
S. suis type 2 OF 20.1 23.2 23.5 22.3 23.9 21.7 20.3 23.3 22.0 21.8 22.5 22.5 19.1 19.2 18.9 21.5 21.5 21.2 
B. bronchiseptica OF    28.6  27.3 28.0 25.4 27.2   25.9 25.9 24.3 24.5  28.2  
PCV3 OF   28.8 22.6 24.9 21.2  28.3  26.3  28.9 17.2  20.8  21.6 16.6 
PPV OF                   
M. hyopneumoniae OF                   
M. hyorhinis OF 23.6 25.5 21.9 24.0 27.8 25.5 19.6 21.4 22.8 23.0 27.4 23.3 19.0 18.7 20.4 20.6 21.7 21.8 
P. multocida OF            26.9 28.7 32.3     
B. pilosicoli FS              20.3    13.4 
L. intracellularis FS     19.7 25.0     11.8 20.5     18.6 25.7 
E. coli F4 FS   24.7    29.9 23.9     16.7      
E. coli F18 FS 25.2 23.6   27.6   17.4 15.9 29.4   18.9 21.1 26.6    
PCV3 FS             25.8     28.7 
PCV2 FS   25.9  25.8 19.8 21.3 12.5   16.1 21.2 24.3 22.6 21.1 16.2 23.2 16.0 
Rotavirus A FS 18.4 22.5  22.4 28.2  19.8 24.0 26.8 24.0 27.5 21.7 19.3 13.0 27.7 24.3 24.8 23.1 
1
1
4
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I) 6N – oral fluid (OF) and faecal sock (FS) samples  
Sampling date September October November 
Days after insertion 17 31 45 17 31 52 15 29 50 
Pathogen  Material Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 
2 
 Pen 1 Pen 2 
swIAV OF  22.1 14.7  14.1   18.4    27.2  22.9 15.9    
H1 (A(H1N1)pdm09) OF     25.2              
PRRSV type 1 OF                   
PRRSV type 2 OF                   
PCMV OF 10.8 16.2 19.0  21.8 19.6 14.7 10.7 14.6 11.3 20.7 23.0 11.0 12.8 12.7 13.2  18.4 
A. pleuropneumoniae OF                24.9   
PCV2 OF 21.9 21.8 16.4  8.5 18.1 22.1 20.6 22.1 22.7 15.8 9.1 19.7 20.2 24.2 23.0 15.9 15.5 
S. suis type 2 OF 25.4 24.5 22.7  22.5 22.0 23.8 23.3 22.8 22.3 20.4 22.2 19.8 21.5 21.7 22.0 22.7 21.8 
B. bronchiseptica OF      26.1   25.8  26.2  27.8 27.7 26.2    
PCV3 OF 29.3  26.5   28.2  27.4   27.0  25.0  24.9 27.7 27.6  
PPV OF     24.1              
M. hyopneumoniae OF                   
M. hyorhinis OF                   
P. multocida OF       27.4  27.3  30.1  24.4  26.2    
B. pilosicoli FS   25.1 23.1 20.0    25.8 21.5 15.1 14.7    20.8 16.2 21.2 
L. intracellularis FS   17.1 18.6 18.6 24.3  14.6  21.2 13.7 19.7   24.9 19.9 14.4 15.3 
E. coli F4 FS             20.4 21.8 27.3    
E. coli F18 FS 20.8 23.3     22.0 25.1     19.9 22.1     
PCV3 FS                30.3   
PCV2 FS   17.2 13.1 13.6 19.5 26.7 20.1   18.8 11.6     19.0 20.3 
Rotavirus A FS 28.6 26.0 24.1 30.1   16.0 23.6 20.6 24.9   18.7 17.3 23.7  22.5  
1
1
5
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J) 6F – oral fluid (OF) and faecal sock (FS) samples  
Sampling date September October November 
Days after insertion 14 30 56 14 42 62 19 40 68 
Pathogen  Material Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 Pen 1 Pen 2 
swIAV OF       21.5      21.7 26.9     
H1 (A(H1N1)pdm09) OF                   
PRRSV type 1 OF                   
PRRSV type 2 OF                   
PCMV OF 21.4 23.1 26.3 24.1   23.3 21.3 21.3 22.1 24.1 21.5 21.4 23.1 21.0 23.3 25.6 26.9 
A. pleuropneumoniae OF 25.4 26.9 25.5 24.1 24.6 25.6   23.7  24.5 23.0  24.9   25.4 22.9 
PCV2 OF 13.7 14.4 14.4 24.4 19.5 20.3 11.5 11.9 12.6 19.0 16.4 15.6 9.0 8.5 18.5 18.0 17.4 13.0 
S. suis type 2 OF 26.1 24.6 21.1 22.7 23.6 23.9 22.4 22.0 23.0 23.6 20.7 19.9 21.0 21.1 24.8 28.6 21.1 23.0 
B. bronchiseptica OF                   
PCV3 OF  28.1 26.9   30.6  23.7 17.1    24.9 24.0 25.9  27.0 25.5 
PPV OF 21.2 14.0 23.8  22.8 24.4 20.2 23.6 18.3 26.5 19.2 26.2 13.6 19.5 20.0 22.2 22.8 22.4 
M. hyopneumoniae OF          22.6  24.5       
M. hyorhinis OF                   
P. multocida OF           28.0 28.0       
B. pilosicoli FS 19.3 20.3 21.2 22.9 19.2 16.7 15.4 17.9 19.0 18.3 17.6 19.6 22.5 16.9 16.8 18.6 17.0 24.0 
L. intracellularis FS  17.1     16.4      19.3 19.5     
E. coli F4 FS 28.0  28.9 27.6               
E. coli F18 FS         25.2    28.9  28.2    
PCV3 FS        25.4 23.7 27.8         
PCV2 FS 16.6 16.8 15.9 17.1 20.8 21.3 13.9 12.8 16.0 20.0 19.6 17.8 10.7 10.2 19.8 20.0 22.9 18.8 
Rotavirus A FS        25.8 29.3 26.8     33.5 26.7 29.0  
1
1
6
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4 Discussion and Perspectives  
Respiratory and intestinal diseases are of major importance in the pig industry as they are known to 
result in production losses due to decreased growth, increased mortality and increased use of 
medication. Respiratory and intestinal diseases in pigs can be caused by a vast number of viruses, 
bacteria and parasites or by the toxins they produce. In some cases, a single pathogen is the cause of 
disease while in others it can be a polymicrobial problem caused by infection with one or more 
pathogens. Furthermore, the diseases can be the result of a multifunctional problem including 
pathogen(s) and e.g. stress factors like environmental, nutritional and psychological. Pigs are often 
housed in large groups and in small spaces, which provides ideal conditions for maintaining 
circulating pathogens. In addition, the continuous flow of new animals lowers the pressure on the 
existing pathogens and allows them to thrive. Pathogens involved in respiratory or intestinal 
diseases in pigs can vary significantly between herds, production sites, regions and countries, which 
makes standardised treatment and control difficult (Heo et al., 2013; Opriessnig et al., 2011). 
Therefore, to keep up with the pathogens and their evolution, accurate diagnostic tools, which 
makes is possible to detect the presence of the infectious agent, is of the outmost importance.      
     Today, the trend in veterinary diagnostics is moving towards the application of rapid methods, 
which can provide definitive answers within 24 hours. These rapid methods should be sensitive and 
specific and be provided at a low cost (Deb and Chakraborty, 2012). Low cost is of high importance 
to veterinary diagnostics, in that the sampling and subsequent laboratory analyses can become an 
expensive affair for the farmer, especially in cases where a high number of samples have to be 
analysed. The high costs caused by either expensive analysis methods or due to a high number of 
samples can lead to limitations in sampling and analysis. On the contrary, the lack of laboratory 
investigations can result in overuse of medication such as antibiotics and can lead to suboptimal 
vaccination programs, since the treatment is based on clinical manifestations instead of actual 
laboratory test results. Therefore, this PhD aimed to develop a new method for veterinary 
diagnostics in which the simultaneous detection of multiple targets, a high sample throughput, high 
sensitivity and specificity were desired. To date, different tools exist for simultaneous detection of 
multiple pathogens, including microarray hybridization, multiplex PCR and sequencing 
(Mcloughlin, 2011). However, an ideal diagnostic system should also possess the ability to handle a 
high number of samples and, therefore, the high-throughput qPCR platform BioMark (Fluidigm) 
was selected for our diagnostic purposes as it allows for simultaneously analysis of multiple 
samples in several assays. This platform has already been applied in several studies investigating 
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expression of immune genes in relation to the presence of pathogens (Skovgaard et al., 2013). More 
recently, the BioMark platform has also been used as surveillance and detection tools for tick-,food- 
and waterborne pathogens (Ishii et al., 2013; Michelet et al., 2014; Spurgeon et al., 2008). However, 
to our knowledge, the high-throughput qPCR platform has not yet been used as a diagnostic tool for 
veterinary pathogens. In the present PhD project, the high-throughput qPCR platform was utilized 
for subtyping of swIAVs. In addition, a highly versatile system was established for screening and 
detection of significant porcine respiratory and enteric pathogens.  
  
In this PhD project, swIAV has been one of the pathogens with most focus due to its importance in 
the Danish pig production. Since 2011, a systematic passive surveillance of swIAVs has been 
conducted in Denmark, which has contributed to a detailed knowledge of the circulating subtypes in 
Danish pigs. Furthermore, surveillance of swIAVs is important due to their zoonotic potential and 
high evolution rate, which can lead to new emerging virus variants (Kuntz-Simon and Madec, 
2009). New reassorted swIAVs have also been discovered during the surveillance in Denmark 
(Breum et al., 2013; Krog et al., 2017). Since pigs can be infected by a multitude of different 
variants of HA and NA, even within a subtype, several PCR assays are necessary to cover all the 
variants, and for conducting adequate analyses. The analysis is always a question of time and cost 
and in order to minimize these, the use of a high-throughput qPCR system was explored for 
subtyping of swIAVs. The high-throughput PCR-based analysis contain RT-qPCR assays targeting 
the different lineages of H1, H3, N1 and N2 circulating in pigs in Europe, together with assays 
specific for the internal genes of A(H1N1)pdm09. By including the pandemic internal genes, a 
more detailed subtyping was obtained compared to more traditionally subtyping (Bonin et al., 2018; 
Henritzi et al., 2016). However, to obtain even more comprehensive subtyping, RT-qPCR assays 
targeting the non A(H1N1)pdm09 internal genes should be included. In order to detect all the 
circulating subtypes, it is important to carry out continuous sequencing of selected isolates. This is 
necessary to maintain the applicability of the PCR-based assays, since sequence changes occur over 
time due to the high mutation- and reassortant rate of IAVs. 
    In addition to swIAV, many respiratory, of which several of these are included in PRDC, and 
enteric pathogens also cause problems in modern pig production. To keep track on these pathogens, 
it is important to have sensitive and specific diagnostic analyses. Each year, the diagnostic 
department of the Danish National Veterinary Institute receives thousands of samples submitted for 
analysis of specific pathogen(s) selected based on the veterinarian´s assessment of the sampled pigs. 
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In return, the diagnostic department provides different analysis packages, allowing for detection of 
three to five pathogens. Furthermore, additional analyses can be chosen for an extra cost. The 
analyses are performed as single qPCR tests, making the diagnostics both costly and time 
demanding especially if the veterinarian or farmer wants the submitted samples to be tested for 
several pathogens. The use of the high-throughput qPCR platform instead of the current low-
throughput qPCR platform for the pathogen detection enables the analysis to be performed in one 
test, which reduces the analysis costs and working time substantially. Furthermore, the possibility 
of including 24, 48 or 96 different qPCR assays, depending of the choice of DA chip, allows for the 
obtaining of a lot of information. To take advantage of this opportunity, a high-throughput 
diagnostic system specific for significant respiratory and enteric viral and bacterial pathogens with 
impact in the Danish pig production was established. For this work, the qPCR assays were designed 
with specificity towards viruses and bacteria, however, to obtain a more adequate analysis the 
inclusion of assays specific for parasites, which are also considered pathogenic in pigs, will be 
necessary. Different types of parasites have been detected in Danish pigs (Joachim et al., 2004; 
Roepstorff et al., 1998; Roepstorff and Jorsal, 1989). Furthermore, a study has found that Ascaris 
suum significantly compromise the effect of M. hyopneumoniae vaccination in pigs (Steenhard et 
al., 2009). Therefore, qPCR assays specific for different types of parasites should be included. 
Likewise, a qPCR assay specific H. parasuis, which is the causative agent of Glässer’s disease 
(Oliveira and Pijoan, 2004), should be included. Initially, an assay specific for H. parasuis was 
included in this work, however, due to unsatisfactory results when using the BioMark platform, the 
assay was removed from the analysis. Instead, further optimizations are required for this assay. 
    We have developed a high-throughput diagnostic system with specificity to seven viruses and ten 
bacteria and the pathogens, which are included in the analysis packages provided by the diagnostic 
department, are among these 17 pathogens. The high-throughput diagnostic system was used for 
objective health monitoring of nursery and finisher pigs in ten pig herds in Denmark. Three 
monthly samplings were conducted in three different age groups in six nursery and four finisher 
herds. The laboratory findings combined with clinical sign observations provided information about 
the pathogen patterns and showed if there was a connection between the presence of pathogens and 
clinical signs. This information can be useful for veterinary consultancy as it provides the herd 
veterinarians with information suitable for determining intervention regimes such as vaccination 
and medication like antibiotic treatment. The veterinarian participating in the project was 
interviewed and indeed confirmed that the results provided useful knowledge for their consultancy. 
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In general, antibiotics are giving to treat or to prevent infections, however, in some countries it is 
also used to increase growth of the animals. Antibiotic consumption in pig production has long been 
on the political and public agenda in Denmark due to the rise in antibiotic-resistant bacteria. During 
the last decades, various measures, including preventing veterinarians from profiting from selling 
antibiotics to farmers and stopping the use of antibiotics as growth promoters, have been taken to 
reduce the consumption of antibiotics in Denmark (Aarestrup, 2012). Furthermore, to reduce the 
antibiotic usage even more sensitive and specific laboratory analyses are important to clarify which 
pathogens are present in the affected herds. Therefore, the combination of high-throughput 
detection and continuous monitoring provides veterinarians with a high information load, and 
thereby forms a good basis for choosing the most optimal treatment. Furthermore, a very detailed 
diagnostic documentation can also be used by the farmer as a scientific argumentation towards the 
authorities in cases where the farmer needs to use much antibiotics and end up in exceeding the 
“yellow card” line. 
 
The distribution of pathogens can change over time and often vary across herds, regions and 
countries (Heo et al., 2013; Opriessnig et al., 2011). Therefore, it is important to adjust the analyses 
according to the different needs. A major advantage of the high-throughput platform is the ease of 
modifying the assay panel through the adding or removing of assays. However, these types of 
qPCR-based assays only provide information about the pathogens which the qPCR test is specific 
for. For some of the sampled pens (manuscript III), in which diarrhoeic events were observed, none 
of the intestinal pathogens included in the qPCR analysis were detected. This could indicate that the 
diarrhoea was caused by another pathogen or as a result of environment or management problems. 
However, this problem could also arise if a pathogen has mutated in the gene, which the qPCR test 
is specific for. When observing symptoms like coughing and diarrhoea without any supportive 
laboratory results it will be a good idea to optimize the test analysis by looking for other relevant 
pathogens. In this project, no further analysis was done in the herds where pens with diarrhoeic 
events were observed due to only sporadic findings.  
     The high-throughput qPCR BioMark platform is a very useful method for analysis of a high 
number of samples in several different assays. Prior to running the DA chip, all of the assay and 
sample inlets have to be loaded with assays and samples, respectively, or with e.g. water. As a 
consequence, this platform is not necessarily beneficial for analysis of only a few samples in a few 
assays unless the samples and assays have to be run in several replicates. However, different types 
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of DA chips with variable technical specifications are available. Another aspect to keep in mind 
when using the high-throughput qPCR platform is the risk of false negative results, which can occur 
if a sample is very positive. Having a very positive sample on the Rotor-Gene Q platform will result 
in an even lower Cq value on the BioMark platform due to the additional pre-amplification. 
Samples with low Cq values will appear light yellow in the heat map, however, the amplification 
curve might not have the right shape, which can question the result. Therefore, in these cases the 
sample should be diluted and re-tested on the BioMark platform. To ensure that the qPCR assays 
were running correctly positive controls for each of the assay were included. When using the 
diagnostic system in which different types of pathogens were targeted, mixes containing several of 
the positive controls were used to minimize the number of inlets used for positive controls. For the 
diagnostic system, the mixes contained up to 13 different positive controls and were successfully 
included in each run. Negative controls are also necessary to include to control for contamination, 
both in the cDNA/pre-amplification run and in the qPCR analysis. Furthermore, to determine if 
factors present in the samples could inhibit the PCR analysis the inclusion of an internal control is 
preferred (Rosenstraus et al., 1998). Another important aspect is to verify if the assays and samples 
have been loaded correctly in the reaction chambers on the DA chip. This can be done in the 
Fluidigm qPCR analysis software by monitoring the ROX data.    
     Several pathogens are commensal inhabits of the respiratory system or intestinal tract and, 
therefore, positive PCR findings does not necessarily equal disease. Therefore, correlation between 
disease and excretion load for a specific pathogen may be expected. Using qPCR enables 
determination of the pathogen load in e.g. faeces, and this measurement can be useful to confirm if 
a pathogen is the microbiological cause of disease or not (Pedersen et al., 2012). Correlation 
between pathogen load and disease severity has been shown to be important for several of the 
intestinal pathogens, since different loads have been associated with specific clinical diseases 
(Grau-Roma et al., 2011; Pedersen et al., 2013; Weber et al., 2017). In the present PhD project, the 
obtained qPCR results have only been given as Cq values for all the included pathogens. However, 
for PCV2, L. intracellularis, B. pilosicoli, E. coli F4 and E. coli F18 the results need to be 
quantitative. Therefore, to improve the high-throughput diagnostic system even further the assays 
should allow for also quantitative analysis of the investigated pathogens. To do so, standard curves  
generated by spiking suspensions of the different pathogens in 10% faeces in ten-fold dilutions 
should be made prior to DNA extraction and run on the high-throughput qPCR platform (Ståhl et 
al., 2011).   
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In the present PhD project, the focus has been on designing a diagnostic system specific for porcine 
pathogens. However, the high-throughput qPCR platform could also be useful as a detection or 
screening tool for pathogens causing disease in other animals or in humans. Like subtyping of 
swIAVs has been conducted using the high-throughput qPCR platform, a corresponding system 
used for subtyping of avian influenza viruses is on the way. This system will be specific for the 
currently detected HA and NA subtypes (Fouchier et al., 2005). Furthermore, a diagnostic system 
specific for bovine pathogens is also being developed and here viruses and bacteria often found in 
cattle are included. So far, qPCR assays specific for Mycoplasma bovis, Mannheimia haemolytica, 
Histophilus somni, bovine respiratory syncytial virus, bovine parainfluenza type 3 virus and bovine 
coronavirus have been designed, however, more assays will be added. Similar system could be 
developed for other important production animals such as poultry and mink or companion animals 
such as cats, dogs and horses. Another interesting application of the system could be to include 
qPCR assays specific for resistant genes, which could provide additional layer of information to the 
analysis especially in relation to antibiotic treatment.     
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5 Conclusion 
The aim of the present PhD project was to establish a cost effective, fast and high-throughput 
laboratory diagnostic system with high sensitivity and specificity to detect pathogens with high 
importance to the Danish pig production. In order to fulfil this aim, the previous low-throughput 
Rotor-Gene Q qPCR platform was replaced with the high-throughput qPCR BioMark platform, 
which allows for the simultaneous detection of different pathogens in a large number of samples. 
     The high-throughput system used for subtyping of swIAVs was developed and verified by 
screening virus isolates and field samples. The use of this system for subtyping enabled the 
determination of both HA and NA genes and to clarify if the virus contains pandemic internal genes 
in the same test. Furthermore, a high-throughput diagnostic system was developed for detection of 
significant respiratory and enteric viral and bacterial pathogens with importance to the health and 
welfare of Danish pigs. The diagnostic system was designed with specificity to 17 selected viruses 
and bacteria. The use of this system for monthly diagnostic monitoring of pathogens in ten Danish 
pig herds showed that the system can be a supportive tool in veterinary consultancy combined with 
clinical observations, which creates a more objective basis for intervention like treatment and 
vaccination strategy. 
     When the diagnostic system is fully implemented and automatized the analysis cost per sample 
will be less than 5% of the cost of traditional qPCR (own calculations) and thereby this system has 
great potential for future disease surveillance of pathogens in production herds. The hope is that the 
lowered costs and time spent on analysis will result in a significant increase in the use of laboratory 
diagnoses, which in turn should provide an objective basis for selection of preventive measures to 
the benefit of animal health, animal welfare, production economics and food safety.  
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